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Abstract
Integrin-linked kinase (ILK) is a ubiquitous scaffold protein essential for the development of
front-rear polarity and directional migration of epidermal keratinocytes. β-arrestin 1 is
another adaptor protein which has recently emerged as a key factor in modulating
proliferation and migration of various cell types. Previous studies have demonstrated an
association between β-arrestin 2 and ILK in cerebellar granule precursor cells. I have now
identified a novel interaction between ILK and β-arrestin 1 in primary keratinocytes that
occurs directly and without post-translational modifications. The N-terminal 67 residues of
ILK and multiple regions in β-arrestin 1 are important for this interaction. This association
occurs regardless of the conformational state of β-arrestin 1. Furthermore, ILK and β-arrestin
1 colocalize at cell extensions, suggesting a possible role for this complex in the development
of front-rear cell polarity and migration. My analysis of this novel interaction provides new
insight into mechanisms of keratinocyte regulation.
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Chapter 1

1

Introduction

1.1

The skin

The skin, as the outermost organ of the body, provides a protective barrier against the
external environment, including physical and chemical insults, pathogens and solar UV
radiation (reviewed in Proksch et al., 2008). The skin also provides thermal regulation,
and contributes to water and electrolyte balance. The skin is made up of two main layers:
the outer epidermis and the inner dermis, and also contains appendages, such as hair
follicles, nails, sebaceous, and sweat glands (reviewed in Rittié, 2016). The dermis is of
mesodermal embryonic origin, and is mainly comprised of fibroblasts and connective
tissue, which provide elasticity and protection against mechanical damage (reviewed in
Morasso and Tomic-Canic, 2005). The dermis is separated from the overlaying epidermis
by a basement membrane composed of extracellular matrix (ECM) proteins secreted by
cells in both tissue layers (Briggaman and Wheeler, 1975).

1.1.1

Overview of the epidermis

The epidermis is a stratified, squamous epithelium of ectodermal origin, and serves as the
first line of defense against chemicals and invasive pathogens (Proksch et al., 2008). The
epidermis undergoes continuous self-renewal to replace old and damaged cells,
maintaining its protective barrier function. Keratinocytes are the predominant cell type
found in the epidermis, although melanocytes, Merkel and Langerhans cells also reside in
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the epidermis. The epidermis is composed of one undifferentiated, highly proliferative
basal layer, followed by several differentiated suprabasal layers termed spinous,
granulosum, lucidum and corneum (Figure 1.1; Rittié, 2016). The innermost basal layer is
composed of two keratinocyte populations, the epidermal stem cells and their progeny,
transit amplifying cells. These two cell types are collectively termed basal keratinocytes,
and exhibit high keratin 5 and 14 (K5/K14) expression (Ghazizadeh and Taichman, 2005;
Mascré et al., 2012). Epidermal stem cells divide either symmetrically (giving rise to two
daughter stem cells) or asymmetrically (giving rise to one stem cell and one transit
amplifying cell), and are characterized by their high β1 integrin expression and long life
span allowing long-term maintenance of all the epidermal layers (Lechler and Fuchs,
2005; Mascré et al., 2012). Conversely, transit amplifying cells are characterized by their
relatively limited proliferative capacity, as they divide a finite number of times before
moving upwards and differentiating to form the suprabasal layers (Mascré et al., 2012).
Proliferation of basal keratinocytes is crucial for sustaining the basal layer. During wound
regeneration, fibroblasts from the underlying dermis can promote basal keratinocyte
proliferation by stimulating these cells with various growth factors, such as keratinocyte
growth factor (KGF) and epidermal growth factor (EGF) (Maas-Szabowski et al., 2000;
Wang et al., 2012; Blumenberg, 2013). Co-culturing keratinocytes with fibroblasts
increases fibroblast expression and secretion of KGF, promoting upregulation of the KGF
receptor in keratinocytes, and increasing proliferation (Maas-Szabowski et al., 2000).
Treatment of cultured mouse and human keratinocytes with EGF induces genes that
regulate cell cycle and promote proliferation, and suppresses expression of pro-apoptotic
genes (Blumenberg, 2013). Additionally, EGF prevents the expression of differentiation
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Figure 1.1. Schematic of the epidermis. The epidermis is comprised of 5 cell layers.
The innermost layer, termed stratum basale, consists of proliferating, undifferentiated
basal keratinocytes. These basal keratinocytes are adhered to the basement membrane
through hemidesmosomes (yellow) and focal adhesions (green). As the cells divide they
move outwards and differentiate along a calcium gradient to give rise to suprabasal
layers, termed stratum spinousum, granulosum, lucidum and corneum. The cells within
the basal, spinous and granulosum layers are held together through cell-cell junctions,
termed desmosomes (green) and adherens junctions (orange), while the cells in the
granulosum layer are adhered tightly to one another through tight junctions (purple).
Keratinocytes within the spinous and granulosum layers produce lamellar bodies (blue
dots). Melanocytes are found within the basal layer and provide keratinocytes with
melanosomes (black dots), which protect the keratinocyte nuclei.
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related genes, and impairment of EGF stimulation results in epidermal barrier defects
(Tran et al., 2012).
Basal keratinocytes also receive signals promoting their differentiation. Keratinocyte
differentiation is crucial for epidermal stratification; however, it is essential that a balance
between the proliferation and the differentiation signals be maintained. For example, the
transcription factor p63 promotes maintenance of the stem population within the basal
layer (Senoo et al., 2007). This transcription factor is highly expressed in epidermal stem
cells, and its depletion results in stem cell proliferation defects (Senoo et al., 2007).
Conversely, p63 also has important roles in keratinocyte differentiation. Down-regulation
of p63 in a regenerating human epidermis results in defective keratinocyte differentiation,
ultimately impeding stratification (Truong et al., 2006). Epiprofin is a cell cycle regulator
and transcription factor that can also regulate both keratinocyte proliferation and
differentiation (Nakamura et al., 2014). Cultures of epiprofin-deficient primary mouse
keratinocytes exhibit decreased proliferative capacity, whereas epiprofin overexpression
promotes expression of differentiation markers and cell cycle exit (Nakamura et al.,
2014). Epiprofin directly binds to the Notch1 promoter, regulating its expression
(Nakamura et al., 2014). Notch1 activation induces spinous layer formation and
delamination of basal keratinocytes, a process in which these cells lose their attachment
to the basement membrane and move outwards (Blanpain et al., 2006). Constitutive
activation of the Notch1 active intracellular domain (NICD) results in expansion of the
spinous layers, detachment from the dermis due to the downregulation of 1 integrin and
p63, and upregulation of keratins 1 and 10 (K1/K10), markers of the spinous layers
(Blanpain et al., 2006; Nguyen et al., 2006).
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Once basal keratinocytes are committed to differentiate, they will continue to move
through the suprabasal layers until they reach the outermost stratum corneum, a process
that takes approximately 4 weeks in humans (Fuchs, 2007).

1.1.2

Epidermal suprabasal layers

As mentioned above, the first suprabasal layer is the stratum spinosum (Figure 1.1).
Keratinocytes within this layer are characterized by the loss of β1 integrin and the switch
from keratins 5/14 to keratins 1/10. Keratins form intermediate filaments that connect
neighbouring keratinocytes through cell-cell junctions termed desmosomes (Fuchs,
2007). The spinous layer also contains Langerhans cells that, in the case of pathogen
invasion, trigger immune responses at the site of entry (Elias, 2007). Keratinocytes within
the spinous layer also begin to produce lamellar bodies, which are lipid-enriched vesicles
that originate from the Golgi apparatus and are ultimately exocytosed in the uppermost
suprabasal layers to form a protective lipid barrier (Fuchs, 2007). As spinous cells move
outwards, they form the stratum granulosum.
Granular keratinocytes form tight cell-cell junctions, which play key roles in the
formation of the permeability barrier of the epidermis (Schlüter et al., 2004; Yoshida et
al., 2013). Granular keratinocytes also synthesize the cornified envelope proteins loricrin
and involucrin, which are then cross-linked during the final stages of differentiation
(Mehrel et al., 1990; Fuchs, 2007). During the transition from granular to cornified cells,
keratinocytes become permeable to Ca2+. The cells begin processing profilaggrin to
filaggrin, a protein that bundles keratin filaments and plays a role in cytoskeletal
intermediate filament reorganization during this transition (Fleckman et al., 1985;

7

Presland et al., 2001). Additionally, cornified envelope proteins are secreted, and the lipid
content of lamellar vesicles is exocytosed into the intercellular spaces within the
overlaying stratum corneum (Proksch et al., 2008). These lipids are then modified and
arranged into intercellular lamellae parallel to the cell surface, and these proteins are
cross-linked through isopeptide bonds formed by Ca2+-dependent transglutaminases. This
gives rise to a protein/lipid cornified envelope, in which the lipid layer is covalently
attached to the underlying protein layer through ester bonds (Kalinin et al., 2002; Nemes
and Steinert, 1999; Swartzendruber et al., 1987).
The stratum corneum consists of keratinocytes termed corneocytes. These cells are flat
and lack nuclei and organelles. Additionally, the surrounding protein/lipid cornified
envelope replaces the plasma membrane, provides the water-impermeable function of the
epidermis, can withstand mechanical stress, and impedes the entry of allergens, chemicals
and microbes (Kalinin et al., 2002; Candi et al., 2005). These cells are ultimately
sloughed off the skin surface, and are replaced by new granular keratinocytes entering
terminal differentiation (Fuchs, 2007).

1.1.3

Integrins in the epidermis

Epidermal homeostasis is maintained via interactions between keratinocytes and their
environment, which are mediated by several factors, including the cell surface molecules
integrins. Integrins, which are a major structural component of focal adhesions, modulate
the actin cytoskeleton through proteins such as talin and vinculin, and are present in
basal, but not in suprabasal keratinocytes (Horton et al., 2015). Two major integrins are
expressed in intact epidermis: 64 and 31, which contribute to adhesion of
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keratinocytes to the basement membrane (Borradori and Sonnenberg, 1999; Nahidiazar et
al., 2015). Integrins α3β1 and α6β4 are located at focal adhesions and hemidesmosomes,
respectively, and bind to extracellular laminin-332, the major ECM component of the
basement membrane. Mice deficient in either the α6, β4 or β1 integrin subunits exhibit
severe blistering due to detachment of the epidermis from the underlying basement
membrane, as well as basal keratinocyte hypoproliferation and epidermal inflammation
(Nahidiazar et al., 2015; Georges-Labouesse et al., 1996; Raghavan et al., 2000).
Integrins also modulate several signaling pathways in the epidermis and other tissues. As
integrins lack catalytic activity, signals generated by their activation are transduced
through recruitment of a variety of proteins their cytoplasmic domains, one of which is
integrin-linked kinase (ILK) (Legate and Fässler, 2009).

1.2

Integrin-linked kinase

Integrin-linked kinase (ILK) is a ubiquitous, 452-amino acid scaffold protein that was
originally identified two decades ago as a β1 integrin-binding factor (Hannigan et al.,
1996). ILK localizes to focal adhesions to link the actin cytoskeleton to ECM
components, and plays an essential role in the establishment and maintenance of cellmatrix adhesions (Hannigan et al., 1996; Zhang et al., 2002). ILK can also be found at
cell-cell junctions in keratinocytes, and at centrosomes and the nucleus in a variety of cell
types (Vespa et al., 2005; Fielding et al., 2008; Nakrieko et al., 2008b).
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1.2.1

ILK structure

ILK contains several structural domains: Five N-terminal ankyrin repeats (ANK), a
central pleckstrin homology (PH)-like domain and a C-terminal pseudokinase (or
“kinase-like”) domain, which has substantial homology to serine/threonine kinases
(Figure 1.2; Hannigan et al., 1996; Chiswell et al., 2008). All 5 ankyrin repeats contain
the classic helix-turn-helix structure, whereas ankyrin repeats 2-4 contain the distinctive
(T)PLH consensus sequence (Chiswell et al., 2008). The PH-like domain, consisting of
residues 180-212, overlaps with the pseudokinase domain (residues 191-452) (Dedhar et
al., 1999).
There has been much debate about the “pseudokinase” domain as it contains an ATPbinding lysine residue (Lys220) and a conserved APE motif, required for substrate
recognition (Figure 1.2; Dedhar et al., 1999). ILK immunoprecipitates and bacterially
produced recombinant ILK has been reported to phosphorylate a variety of substrates in
in vitro kinase assays, including myelin basic protein, the cytoplasmic domain of β1
integrin, β-parvin, PKB/Akt and GSK3β (Hannigan et al., 1996; Yamaji et al., 2001;
Persad et al., 2001; Maydan et al., 2010). However, many studies since have not been
able to verify these observations. First, ILK does not possess two conserved key kinase
motifs: the HRD motif which is required for proton transfer, and the DFG motif which
binds Mg2+ and ensures proper alignment of the β- and γ-phosphates of ATP in the ATP
binding pocket (Boudeau et al., 2006). ILK also has an altered ATP-binding loop, where
a non-glycine rich sequence in ILK has replaced the well-conserved glycine-rich
GXGXXG motif found in bona fide kinases (Fukuda et al., 2009). Moreover, the ATP
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Figure 1.2. Structural domains and sequence of Integrin-linked kinase (A) ILK is
composed of several structural domains: five N-terminal ankyrin repeats (numbers 1-5), a
central pleckstrin homology (PH)-like domain, and a C-terminal “kinase-like” domain
(KLD). (B) The ankyrin repeats contain two helices each, and lines are drawn above the
residues that make up each helix. The ATP-binding lysine (Lys220) is written in red and
the kinase conserved APE motif is written in blue. Amino acid residues 180-212 which
form the PH-like domain are indicated by a pink line. Homo sapiens, NCBI Accession:
AAC16892.1
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MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQCPGRMYAPAWVAPEA 360

ILK 361

LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 420

ILK 421

VCKLMKICMNEDPAKRPKFDMIVPILEKMQDK 452
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binding pocket is also a site for the ILK binding partner, parvin, and ATP cannot
effectively displace this protein to then bind ILK (Fukuda et al., 2009). Thus, although
ILK can bind ATP through Lys220, it is unable to hydrolyze it due to an altered
conformation unfavourable for hydrolysis (Fukuda et al., 2009). These studies also
reported that recombinant ILK failed to phosphorylate myelin basic protein and the
cytoplasmic tail of β1 integrin (Fukuda et al., 2009).
Additional evidence for the concept that ILK is a pseudokinase has been provided by
studies using the mutant ILK E359K, which contains a point mutation in a conserved
glutamic acid residue in the substrate binding loop that is essential for catalytic function
of bona fide kinases and was originally described as a kinase-dead mutant (Persad et al.,
2001). However, expression of ILK E359K does not change the phosphorylation of Akt
or GSK3β in kidney fibroblasts (Sakai et al.. 2003). In vitro kinase assays with
immunoprecipitates from HeLa and COS-7 cells expressing ILK E359K exhibit the same
kinase activity as immunoprecipitates from wild-type ILK-expressing cells (Yamaji et al.,
2001; Nikolopoulos and Turner, 2002). ILK-deficient chondrocytes, fibroblasts and
keratinocytes show comparable levels of phosphorylated PKB/Akt and GSK3β as ILKexpressing cells (Grashoff et al., 2003; Sakai et al., 2003; Lorenz et al., 2007).
In vivo studies also support the notion that ILK lacks kinase activity. An elegant study
published by Lange et al., (2009) reported that knock-in mice carrying point mutations in
the Ilk gene that were previously reported to affect kinase activity display a normal
phenotype and are indistinguishable from wild-type controls (Lange et al., 2009).
Similarly, studies with Drosophila melanogaster and Caenorhabditis elegans have
demonstrated that the presumed ILK kinase activity is dispensable for their development
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(Zervas et al., 2001; Mackinnon et al., 2002). Finally, X-ray crystallographic,
biochemical and thermodynamic analyses of the pseudokinase domain of ILK have
provided further evidence that it does not exhibit phosphotransferase activity (Fukuda et
al., 2011). It is likely that ILK scaffolds functional kinases which are responsible for the
phosphorylation of the tested targets (Qin and Wu, 2012).

1.2.2

Biological functions of ILK

ILK expression is essential for development. ILK-deficient mouse embryos fail to
implant due to defective actin cytoskeleton organization and polarization of the epiblast
(Sakai et al., 2003). Inactivation of genes encoding ILK orthologues also results in
embryonic lethality in other organisms, including Caenorhabditis elegans, Drosophila
melanogaster and Xenopus laevi. Tissue-specific inactivation of ILK results in impaired
development in every tissue examined to-date (reviewed in Wickström et al. 2010a).
Elevated ILK expression is also detrimental and is associated with multiple human
malignancies (McDonald et al., 2008).
ILK is vital for focal adhesion formation, as ILK-deficient fibroblasts examined by cryoelectron tomography show severe changes in their focal adhesions, characterized by a
disarray of associated actin filaments (Elad et al., 2013). Similarly, ILK-deficient
chondrocytes exhibit an altered cell morphology, adhesion and spreading defects, and
form fewer focal adhesions (Grashoff et al., 2003). ILK regulates focal adhesion
formation through its interaction with various adaptor proteins, including Particularly
Interesting New Cysteine-Histidine protein (PINCH) and parvins, collectively termed the
IPP complex (ILK-PINCH-parvin complex) (Tu et al., 1999). PINCH and parvins bind to
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ILK prior to localization of this complex to focal adhesions (Zhang et al., 2002). PINCH
binds to the ANK region of ILK, whereas parvins (α, originally termed CH-ILKBP; β,
originally termed affixin; and γ) interact with the ILK pseudokinase domain (Tu et al.,
1999; Tu et al., 2001; Yamaji et al., 2001; Zervas et al., 2011). The IPP complex localizes
to focal adhesions, and regulates cell adhesion and actin cytoskeleton organization
through a direct interaction with F-actin (Tu et al., 2001; Yamaji et al., 2001; Ciobanasu
et al., 2016). Disruption of the IPP complex prevents ILK localization to focal adhesions
and interferes with F-actin dynamics. In HeLa cells, disruption of the IPP complex
inhibits cell spreading and migration, and induces apoptosis (Fukuda et al., 2003).
In Drosophila melanogaster, the IPP complex is recruited to focal adhesions through
interaction with the protein talin, and this recruitment increases the number of muscle-totendon attachment sites (Zervas et al., 2011). This study also demonstrated that the IPP
complex is assembled sequentially and that ILK is essential for PINCH stability (Zervas
et al., 2011). Similarly, ILK binding is essential for localization of PINCH to focal
adhesions in CHO cells and in rat embryonic fibroblasts, and disruption of the IPP
complex by exogenous expression of an N-terminal ILK fragment or an ILK-bindingdefective PINCH mutant prevents focal adhesion formation, cell spreading and motility
(Zhang et al., 2002).
ILK also forms complexes with multiple other proteins (Dobreva et al., 2008a), some of
which are summarized in Table 1.1. ILK interacts with another focal adhesion protein,
paxillin. This interaction is constitutive and necessary for focal adhesion formation in
multiple cell types (Nikolopoulos and Turner, 2001; Nikolopoulos and Turner, 2002;
Chun et al. 2003). In oligodendrocytes, the interaction between ILK and paxillin is
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important for their responses to laminin-211 during axon myelination (Chun et al., 2003).
Expression of ILK E359K, which is unable to interact with paxillin, inhibits
oligodendrocyte spreading (Chun et al., 2003).
Table 1.1: ILK-binding proteins.
Protein

Reference

β1-integrin

(Hannigan et al., 1996)

c-Src

(Kim et al., 2008)

ELMO2

(Ho et al., 2009)

ILKAP

(Leung-Hagesteijn et al., 2001; Nakrieko et al., 2008)

IQGAP1

(Dobreva et al., 2008; Wickström et al., 2010b)

Parvin (α, β, γ)

(Tu et al., 2001; Yamaji et al., 2001)

Paxillin

(Nikolopoulos and Turner, 2001)

PINCH

(Tu et al., 1999)

Rictor

(Dobreva et al., 2008; McDonald et al., 2008)

RuvB-like1

(Dobreva et al., 2008; Fielding et al., 2008)

Microtubules (α and β)

(Dobreva et al., 2008)

ILK can also modulate F-actin reorganization and cell spreading through its interactions
with phosphorylated c-Src, which in turn induces cofilin phosphorylation and F-actin
rearrangment at the leading edge of migrating intestinal epithelial cells (Kim et al., 2008).
ILK-c-Src interactions facilitate cross-talk between integrins and the fibroblast growth
factor (FGF) receptor, promoting dorsal ruffle formation in fibroblasts (Azimifar et al.,
2012). In this context, ILK regulates the spatiotemporal activation of c-Src at focal
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adhesions, and ILK-deficient fibroblasts have lower levels of activated c-Src localized to
focal adhesions.
ILK is also required for transforming growth factor-β 1 (TGF-β1)-induced differentiation
of fibroblasts into myofibroblasts (Vi et al., 2011). ILK-deficiency impairs the formation
of mature focal adhesions and the contractile capacity of fibroblasts (Vi et al., 2011).
Additional studies using a rat in vivo model and cultured human fibroblasts demonstrated
that ILK is required for migration and wound healing, as ILK-silencing decreases
fibroblast migration and differentiation (Li et al., 2016). ILK-deficient fibroblasts also
show significantly impaired chemotaxis towards platlet-derived growth factor (PDGF)
and FGF (Azimifar et al., 2012). In keratinocytes, ILK forms tripartite complexes with
ELMO2 and RhoG at lamellipodia, that mediate the development of front-rear polarity
and directional migration (Ho et al., 2009). In breast and prostate carcinoma cells, ILK
colocalizes with Rictor, another protein involved in cytoskeleton regulation, along the
leading edge of migrating cells (McDonald et al., 2008).
ILK directly binds to microtubules and has important roles in regulating microtubule
stability and growth (Wickström et al., 2010b; Jackson et al., 2015). Overexpression of
ILK promotes microtubule growth, whereas ILK-deficiency alters microtuble dynamics
and increases microtubule catastrophe (Lim et al., 2013; Jackson et al., 2015). ILK
localizes to centrosomes and microtubule organizing centers in dividing cells, where it
regulates mitotic spindle assembly through direct interactions with the microtubule
stabilizing proteins, ch-TOG and RuvB-like 1 (Fielding et al., 2008; Dobreva et al.,
2008). This interaction is essential for localization of ch-TOG and RUVBL-1 to
centrosomes, maintenance of RuvB-like 1-tubulin association, spindle assembly and
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progression through mitosis (Dobreva et al., 2008; Fielding et al., 2008). ILK also forms
a complex with IQGAP1, an F-actin- and microtubule-binding protein, and recruits
IQGAP1 to the cell cortex, which stabilizes the link between microtubules and integrins,
and regulates caveolae formation and trafficking in undifferentiated keratinocytes
(Wickström et al. 2010b).
ILK translocation into the nucleus involves active, energy-dependent transport through
the nuclear pore (Nakrieko et al., 2008b). Studies in MCF-7 cells attribute this
translocation to a nuclear localization sequence (NLS) composed of amino acid residues
Lys363-Arg371; however, other studies performed in keratinocytes have mapped the
nuclear localization region to the first 31 residues of the N terminus. ILK
nucleocytoplasmic shuttling is regulated through a p21-activated kinase 1 (PAK1)
phosphorylation-dependent mechanism and via Chromosome region maintenance 1
(CRM1)-mediated export, which is stimulated through an interaction with integrin-linked
kinase associated protein (ILKAP), a type 2C protein phosphatase (Acconcia et al., 2007;
Nakrieko et al., 2008b). Localization of ILK to the nucleus appears to be important for
regulating nuclear integrity, as expression of ILK mutants incapable of localizing to the
nucleus induces abnormal nuclear protein distribution and altered nucleus morphology
(Acconcia et al., 2007). Nuclear ILK also regulates DNA synthesis (Nakrieko et al.,
2008b; Acconcia et al., 2007).
ILK has important roles in modulating cell proliferation. In cerebellar granule precursor
cells, ILK is required for translocation of the GPCR Smoothened (Smo) to the base of
primary cilia (Barakat et al., 2013). This translocation requires association with β-arrestin
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2, and results in activation of the downstream transcription factor, Gli2, and ultimately
cellular proliferation (Barakat et al., 2013).

1.2.3

Biological functions of ILK in the epidermis

ILK is present throughout all epidermal layers, and in both undifferentiated and
differentiated cultured primary keratinocytes, which model keratinocytes found in the
basal and suprabasal layers, respectively (Vespa et al., 2005). A genome-wide analysis of
the ILK-expressing versus ILK-deficient epidermal transcriptome showed that ILK
modulates expression of over 700 genes, including those involved in epidermal
pigmentation, regeneration, cytoskeletal dynamics and hair follicle morphogenesis (Judah
et al., 2012). Mice with keratinocyte-specific deletion of the Ilk gene exhibit severe
abnormalities in epidermal adhesion (Nakrieko et al., 2008a). These mice have fragile
skin and blisters due to epidermal detachment from the basement membrane (Lorenz et
al., 2007, Nakrieko et al., 2008a). Likewise, cultured ILK-deficient keratinocytes fail to
attach and spread normally on laminin-332, the major substrate found in the basement
membrane (Nakrieko et al., 2008a). Further, an abnormal distribution of α6β4 integrins in
the ILK-deficient epidermis, which are an essential component of hemidesmosomes, has
been reported (Lorenz et al., 2007; Nakrieko et al., 2008a).
ILK modulates front-rear cell polarity and directional migration of epidermal
keratinocytes (Lorenz et al., 2007; Nakrieko et al., 2008a; Ho et al., 2009). Activation of
the Rho GTPase Rac1, is crucial for the formation of lamellipodia. Keratinocytes
deficient in ILK show decreased Rac1 activation, defective lamellipodia stability, and a
reduced migratory capacity (Lorenz et al., 2007; Nakrieko et al., 2008a). ILK-deficient
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keratinocytes also show abnormalities in differentiation (Nakrieko et al., 2008a). The
suprabasal layers within the ILK-deficient epidermis express K14, a marker of
undifferentiated keratinocytes, and β1 integrin (Lorenz et al., 2007; Nakrieko et al.,
2008a). In vitro studies have attributed these differentiation abnormalities to defective
actin remodeling, cell-cell junction assembly and impaired Ca2+-sensing receptor
translocation to the membrane (Sayedyahossein et al., 2016).
Additionally, ILK-deficient mouse epidermis appears to have reduced pigmentation
(Nakrieko et al., 2008a). In the epidermis, keratinocytes take up melanin-containing
melanosomes released by melanocytes, which provide keratinocytes with protection
against UV radiation and give the epidermis its colour (Cardinali et al., 2005). Cultured
ILK-deficient keratinocytes have defective phagocytic capability, which may in turn
contribute to the reduced pigmentation of ILK-deficient epidermis (Sayedyahossein et al.,
2012).
ILK is essential for the development of epidermal appendages, such as hair follicles. In
vivo studies have demonstrated that hair follicles in ILK-deficient mice develop similarily
to ILK-expressing mice up to embryonic day 16.5 (Rudkouskaya et al., 2014). However,
ILK-deficient hair follicles are fewer in number, under-developed, and fail to invaginate
into the dermis (Nakrieko et al., 2008a; Rudkouskaya et al., 2014). These differences are
due, at least in part, to the decreased proliferation of ILK-deficient follicular
keratinocytes, impaired responses to Wnt, and altered laminin-511 deposition, the main
component of the basement membrane surrounding the follicular epithelium (Nakrieko et
al., 2008a; Rudkouskaya et al., 2014).
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1.3
1.3.1

β-arrestin 1
The arrestin family of scaffold proteins

Arrestins are a family of proteins that are essential for desensitization and internalization
of many G protein-coupled receptors (GPCRs) (Ferguson et al., 1996; Goodman et al.,
1996; Laporte et al., 1999). To-date, four members of the arrestin gene family have been
identified: visual arrestin (arrestin-1), β-arrestin 1 (also termed arrestin-2), β-arrestin 2
(also termed arrestin-3) and cone arrestin (arrestin-4) (Kühn et al., 1984; Benovic et al.,
1987; Attramadal et al., 1992; Craft et al., 1994). Visual and cone arrestins have
specialized functions in the retina, whereas β-arrestins are ubiquitous. β-Arrestin 1 was
originally identified as a visual arrestin homolog required for the desensitization of the
activated and phosphorylated β2-adrenergic receptor (β2AR) (Benovic et al., 1987; Lohse
et al., 1990). Shortly thereafter, β-arrestin 2, with 78% sequence homology to β-arrestin
1, was identified (Figure 1.3; Attramadal et al., 1992). In addition to receptor
desensitization, β-arrestins also regulate GPCR trafficking (Ferguson et al., 1996). GPCR
phosphorylation facilitates their interaction with β-arrestins and the endocytic machinery
(Ferguson et al., 1996).

1.3.2

β-arrestin structure

-arrestin 1 and 2 have 418 and 409 amino acids, respectively. Three conformations have
been

described

for

these

proteins:

basal

(“inactive/closed”),

receptor-bound

(“active/open”) and microtubule-bound (Hanson et al., 2006). -Arrestins are composed
of two domains comprised of -strands: an N-domain (residues 1-173 in -arrestin 1),
and a C-domain (residues 186-418 in -arrestin 1), which are connected by a 12-residue
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Figure 1.3. Structure of β-arrestin 1 and comparison between non-visual arrestin
sequences. (A) β-arrestin 1 is composed of two domains: the N- and C-domain, made up
of β-strands, connected by a 12-residue inter-domain hinge (IDH). (B) The non-visual
arrestins share 78% sequence homology. The amino acid residues of each β-strand and αhelix are indicated with a black line. The inter-domain hinge is written in yellow. The
five amino acid residues that make up the polar core are written in red. The blue box
highlights the nuclear localization sequence (NLS). The purple box surrounds the nuclear
export sequence (NES) and the one residue of the NES that differs between β-arrestin 1
and 2 (Q395L) is written in purple. β-Arrestin 1 (β1), Rattus norvegicus, NCBI
accession: AAA74459.1; β-arrestin 2 (β2), Rattus norvegicus, NCBI accession:
NP_037043.1
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II
III
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XVI
II
Lariat
ADICLFNTAQYKCPVAMEEADDTVAPSSTFCKVYTLTPFLANNREKRGLALDGKLKHEDT
ADICLFSTAQYKCPVAQLEQDDQVSPSSTFCKVYTITPLLSDNREKRGLALDGQLKHEDT
******+********* * ** *+**********+** *++***********+******

298
300

β1 299
β2 301

III
XVIII
XIX
NLASSTLLREGANREILGIIVSYKVKVKLVVSRGGLLGDLASSDVAVELPFTLMHPKPKE
NLASSTIVKEGANKEVLGILVSYRVKVKLVVSRGG--------DVSVELPFVLMHPKPHD
******+++****+*+***+***+***********
**+***** ****** +

358
352

β1 359
β2 353

XX
EP----PHREVPESETPVDTNLIELDTN---DDDIVFEDFARQRLKGMKDDKDEEDDGTG
HITLPRPQSAPREIDIPVDTNLIEFDTNYATDDDIVFEDFARLRLKGMKDDDCDDQFC-*+
* + ********+***
*********** ********+ +++¬

411
410

β1 412
β2 411

SPHLNNR 418
------- 410

59
60

23

inter-domain hinge region (Figure 1.3; Gurevich and Gurevich, 2013). The N-domain is
more flexible than the C-domain, and also contains an amphipathic α-helix which serves
as a reversible membrane anchor to stabilize the β-arrestin-GPCR interaction (Han et al.,
2001). The C-domain contains the “C-tail” which is essential for interactions with the
endocytic machinery (Han et al., 2001; Nobles et al., 2007a). Two key intramolecular
interactions maintain -arrestins in the basal “closed” conformation. A region containing
bulky hydrophobic residues from the N- and C-domain, referred to as the three-element
region, and a polar core region composed of solvent-excluded charged residues (Asp26,
Arg169, Asp290, Asp297 and Arg393), that includes a salt bridge formed between Arg169 of
the N-domain and Asp289 of the C-domain (Figure 1.3; Vishnivetskiy et al., 1999; Kovoor
et al., 1999; Vishnivetskiy et al., 2000; Han et al., 2001; Nobles et al., 2007). Disruption
of either of these intramolecular interactions results in rotation of the N- and C-domains
relative to each other, yielding a more dynamic and open conformation (Shukla et al.,
2013; Kim et al., 2015a). In addition to the polar core and the three-element region, the
C-tail also stabilizes the basal conformation, as truncation mutants lacking the C-tail have
a constitutively “open” conformation similar to the receptor-bound protein (Kim et al.,
2013).
β-Arrestins 1 and 2 have slightly different basal and receptor-bound conformations,
which accounts for the differences in their GPCR selectivity. β-Arrestin 2 has a more
flexible inter-domain hinge region and polar core than β-arrestin 1. During GPCR
binding, the residues within the polar core are repositioned and the inter-domain hinge
rotates to open up the β-arrestin molecule. These differences account for the broader
GPCR selectivity of β-arrestin 2 (Nobles et al., 2007; Yun et al., 2015; Kim et al., 2015).
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β-Arrestins define two major classes of GPCRs based on their effect on receptor
internalization (Oakley et al., 2000). Class A GPCRs, such as 2AR and the endothelin
type A receptor (ETAR), preferentially internalize through β-arrestin 2-only mechanisms,
and the β-arrestin/GPCR interaction is transient (β-arrestin does not internalize with these
receptors). Conversely, Class B GPCRs, which include the angiotensin II type 1A
receptor (AT1AR) and the vasopressin V2 receptor (V2R), have no preference for βarrestin 1 or 2, but the β-arrestin/GPCR interaction is more stable (β-arrestin will
internalize in endosomes with the receptor).
β-Arrestins contain a 7-amino acid nuclear localization sequence (NLS) within their Ndomain, including Lys157-Arg161/Arg169-Lys170 (Hoeppner et al., 2012). Mutagenesis
studies have shown that Lys157 is required for interactions with importin β1 and nuclear
import (Figure 1.3; Hoeppner et al., 2012). In addition, β-arrestin 2, but not β-arrestin 1,
has a classical leucine rich nuclear export sequence (NES) in its C-domain containing
residues Leu395/Leu397 (Figure 1.3; Scott et al., 2002). Thus, only β-arrestin 2 is exported
from the nucleus by CRM1. In the corresponding region of β-arrestin 1 there is a
glutamine in place of Leu395 (Figure 1.3; Scott et al., 2002; Wang et al., 2003).

1.3.3

Biological functions of β-arrestin 1

Mice deficient in either β-arrestin 1 or β-arrestin 2 are overtly normal; however, depletion
of both β-arrestins is embryonically lethal indicating that the presence of both β-arrestins
is not required for development and suggesting that deficiency in one β-arrestin promotes
phenotypic compensation by the other (Conner et al., 1997; Kohout et al., 2001). βArrestins have an essential role in the desensitization of GPCRs. Activated GPCRs are
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phosphorylated by GPCR kinases (GRKs). This promotes β-arrestin binding to the
GPCR, which in turn, physically interrupts and blocks the interaction between receptors
and heterotrimeric G proteins, resulting in signal termination (as reviewed in Ferguson et
al. 1996). During desensitization, the GPCR is internalized through a β-arrestindependent mechanism. β-Arrestin 1 mediates GPCR trafficking through its interaction
with clathrin and adaptor protein AP-2 (Table 1.2; Goodman et al., 1996; Laporte et al.,
2000). β-Arrestin 1 binds to clathrin through a LIELD amino acid sequence (amino acid
residues 376-380) and to AP-2 through amino acid residues Phe391 and Arg395 (Goodman
et al., 1996; Kim and Benovic, 2002; Milano et al., 2002; Laporte et al., 2000; Kim and
Benovic, 2002). These interactions are essential for targeting GPCRs to clathrin coated
pits and their subsequent internalization (Kim and Benovic, 2002). Phosphoinositides,
such as phosphatidylinositol 4,5-bisphosphate (PIP2) and inositol hexaphosphate (IP6),
are also important components of the endocytic machinery (Milano et al., 2002). βarrestin 1 binding of phosphoinositides is critical for delivery of the receptor-β-arrestin 1
complex to the clathrin coated pits by providing a means of β-arrestin 1 attachment to the
plasma membrane (Gaidarov et al., 1999). Furthermore, β-arrestin 1-mediated receptor
internalization is not restricted to GPCRs. β-Arrestin 1 can also promote clathrinmediated endocytosis of the insulin-like growth factor 1 receptor (IGF1R) (Lin et al.,
1998).
β-Arrestins can also initiate a second-wave of GPCR signaling by serving as bridges
between GPCRs and a variety of signalling proteins, such as members of the MAPK
pathway and others listed in Table 1.2 (Daaka et al., 1998; Luttrell et al., 1999; DeFea et
al., 2000). A ground breaking study demonstrated that β-arrestin 1, through a proline-rich
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region in the N-domain, interacts with and recruits c-Src to the GPCR (Luttrell et al.,
1999). This interaction is essential for ERK phosphorylation, as β-arrestin 1 mutants
unable to bind to c-Src act as dominant negative inhibitors of GPCR-mediated ERK
activation (Luttrell et al., 1999; DeFea et al., 2000). β-Arrestin 1 also binds to
components of the MAPK cascade, allowing them to activate one another (Pierce et al.,
2000; Ge et al., 2003). For example, β-arrestin 1 complexes with MEK1, ERK1/2 and
Raf-1, to provide the appropriate spatial arrangement for the phosphorylation of ERK1/2
(Meng et al., 2009).
Table 1.2: β-arrestin 1-binding proteins.
Protein

Reference

Adaptor protein AP-2

(Laporte et al., 2000)

ARHGAP21

(Anthony et al., 2011)

Clathrin

(Goodman et al., 1996)

Cofilin

(Zoudilova et al., 2007)

ERK1/2

(Coffa et al., 2011)

Filamin A

(Hanson et al., 2007)

IĸBα

(Witherow et al., 2004)

Importin β1

(Hoeppner et al., 2012)

c-Raf1

(Coffa et al., 2011)

Microtubules (α, β and γ)

(Hanson et al., 2007)

MEK1

(Meng et al., 2009)

Phosphoinositides (PIP2, IP6)

(Milano et al., 2002)

c-Src

(Luttrell et al., 1999)
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The β-arrestin 1-MAPK interaction promotes pseudopodia formation and migration in
mouse embryonic fibroblasts (MEFs) (Ge et al., 2003). Protease activated receptor 2
(PAR-2) activation induces the formation of endosomal β-arrestin 1-PAR-2-Raf-1MEK1-ERK complexes along the membrane, and promotes actin reorganization,
extensions of pseudopodia, and migration of MEFs (Ge et al., 2003). Silencing of βarrestin 1 in MDA MB-231 metastatic breast cancer cells abolishes PAR-2-induced
migration (Ge et al., 2004).
β-Arrestin 1 can also participate in F-actin organization through its interaction with
filamin A, an actin cross-linking protein (Scott et al., 2006). The β-arrestin 1-filamin A
interaction promotes ERK phosphorylation and membrane ruffling in Hep2 cells (Scott et
al., 2006). In addition, β-arrestin 1 regulates cofilin activation and localizes cofilin and Factin to cell protrusions (Zoudilova et al., 2007). β-Arrestin 1 also interacts with
ARHGAP21, a RhoA regulator that inhibits RhoA activity (Anthony et al., 2011). βArrestin 1-ARHGAP21 interaction precludes inhibition of RhoA, thus allowing RhoA
activation and stress fiber formation in response to angiotensin II (Anthony et al., 2011).
Disruption of the β-arrestin 1-ARHGAP21 interaction through peptide inhibition results
in active ARHGAP21 and attenuation of angiotensin II-induced stress fiber formation
(Anthony et al., 2011).
β-Arrestin 1 also directly binds to microtubules (Hanson et al., 2007). β-Arrestin 1
localizes to centrosomes where it interacts with γ-tubulin, and regulates microtubule
nucleation and growth. Depletion of β-arrestin 1 produces multinucleated cells with
abnormal centrosome number and size. These defects are rescued with expression of
exogenous β-arrestin 1 (Shankar et al., 2010). Additionally, β-arrestin 1- and 2-deficient

28

MEFs exhibit impaired microtubule targeting to focal adhesions and a decreased
migratory capacity compared to the -arrestin 1 and 2-expressing MEFs. Normal
phenotypes are restored with the exogenous expression of β-arrestin 1, suggesting that βarrestin 1 is involved in the delivery of microtubules to focal adhesions (Cleghorn et al.,
2015). β-Arrestin 1 is also involved in the rapid disassembly of focal adhesions, as arrestin 1-deficiency increases the size and number of focal adhesions in MEFs (Cleghorn
et al., 2015).
β-arrestin 1 regulates transcription directly and indirectly. For example, β-arrestin 1 can
bind to IĸBα, which in turn binds to NFĸB, a transcription factor that regulates
expression of genes involved in inflammation and autoimmune responses (Witherow et
al., 2004). Binding of β-arrestin 1 to this complex inhibits NFĸB translocation to the
nucleus. Similarly, β-arrestin 1 binding to ERK1/2 decreases its translocation to the
nucleus, preventing activation of transcription factors such as the ETS family protein Elk
1 (Tohgo et al., 2003).
Additional studies have demonstrated that β-arrestin 1 can translocate into the nucleus
and bind to the promotor region of several genes, including c-fos and p27, and recruit
transcription cofactors, such as the histone acetyltransferase p300 and the cAMPresponse element-binding protein (CREB) to those promoters. This activates transcription
and regulates cell growth (Kang et al., 2005; Hoeppner et al., 2012).

1.3.4

β-arrestin 1 and its role in the epidermis

The functions of β-arrestins in the epidermis are largely unknown. To-date, only a
handful of studies have investigated β-arrestins in the epidermis, and most have examined
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the function of β-arrestin 2. β-Arrestin 2 regulates immune cell infiltration into the
epidermis and prevents allergic responses in the skin (Gaffal et al., 2014). Mice deficient
in β-Arrestin 2 experience severe inflammation and thickening of the skin at the site of
allergen application (Gaffal et al., 2014). In vitro studies attribute these abnormalities to
the excessive production of chemokines by β-arrestin 2-deficient keratinocytes in
response to allergen-specific T-cell stimulation. Together, this suggests that β-arrestin 2
inhibits the production of pro-inflammatory chemokines, ultimately regulating allergic
skin responses (Gaffal et al., 2014).
β-Arrestin 2 also regulates epidermal responses to UV radiation (Luan et al., 2005). βArrestin 2 complexes with IκBα and NFκB, inhibiting NFκB activation. Depletion of βarrestin 2 in human squamous carcinoma cells, increases expression of anti-apoptotic
genes, whereas exogenous expression of β-arrestin 2 promotes UV-induced apoptosis
(Luan et al., 2005). β-Arrestin 2 also modulates angiotensin II-induced keratinocyte
migration. In this context, β-Arrestin 2 mediates activation of TGF-β1, consequent
activation of the TGF-β receptor, and transactivation of the EGF receptor. Silencing of βarrestin 2 in keratinocytes inhibits these effects and attenuates keratinocyte migration
(Sakai et al., 2015).
β-arrestin 2 is also required for chemokine-induced migration of melanocytes. In this
context, β-arrestin 2 acts downstream of the stromal derived factor 1 (SDF-1)-stimulated
CXCR7 receptor to induce ERK phosphorylation and migration of melanocytes (Lee et
al., 2013).
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Finally, β-arrestin 1 is required for keratinocyte proliferation, and is implicated in
development of mouse skin papillomas (Chun et al., 2009; Chun et al., 2010). Stimulation
of the prostaglandin E(2) receptor promotes β-arrestin 1-Src complex formation. Levels
of β-arrestin 1-Src complexes are elevated in human papillomas (Chun et al., 2009).
These β-arrestin 1-Src complexes in turn, activate the EGF receptor, and promote
activation of ERK and Akt, ultimately increasing cell proliferation.

1.4

Rationale, hypothesis and aims

Recent evidence demonstrates a selective cilium-restricted association between β-arrestin
2 and ILK in cerebellar granule precursor cells (Barakat et al., 2013). These results, in
conjunction with the vast number of studies demonstrating that ILK and β-arrestin 1,
separately, regulate migration in multiple cell types, leads me to hypothesize that βarrestin 1 and ILK directly bind one another and can be found at membrane
extensions where they cooperate in promoting keratinocyte migration. To test this
hypothesis, the specific aims of this study are:
1. To determine if β-arrestin 1 and ILK associate in keratinocytes.
2. To identify what domains of each protein may be involved in their association.
3. To determine patterns of subcellular colocalization of β-arrestin 1 and ILK.
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Chapter 2

2

Materials and Methods

2.1

Reagents and Materials

Reagents, materials and their source are listed in Table 2.1.
Table 2.1: Reagents and materials
Reagents and materials

Source

Catalogue No.

Amersham ECL Prime Western
Blotting Detection Reagent

GE Healthcare Bio-Sciences,
Mississauga, ON

RPN2232

Aprotinin

BioShop, Burlington, ON

APR200

Bio-Rad Protein Assay Dye
Reagent Concentrate

Bio-Rad Laboratories Inc.,
Hercules, CA

500-0006

Albumin Bovine Serum (BSA)

BioShop, Burlington, ON

ALB001

Ca2+-free Eagle’s Minimum
Essential Medium (EMEM)

Lonza, Walkersville, MD

06-174G

Chelex 100 Resin

Bio-Rad Laboratories Inc.,
Hercules, CA

142-2832

Cholera Toxin

Sigma-Aldrich, St. Louis, MO

Coomassie Brilliant Blue R-250

Bio-Rad Laboratories Inc.,
Hercules, CA

Dispase® II

Roche, Indianapolis, IN

Dithiothreitol (DTT)

BioShop, Burlington, ON

Epidermal growth factor (EGF)

Sigma-Aldrich, St. Louis, MO

E4127

Fetal bovine serum (FBS)

Gibco, Burlington, ON

12483

C8052
161-0400
4942078001
DTT001
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Reagents and materials

Source

Catalogue No.

HisPur™ Ni-NTA Resin

Thermo Fisher Scientific,
Rockford, IL

88221

Hoescht 33342

Life Technologies, Carlsbad,
CA

H1399

Hydrocortisone

Sigma-Aldrich, St. Louis, MO

H4001

Dulbecco’s Modified Eagle
Medium – high glucose
(DMEM)

Sigma-Aldrich, St. Louis, MO

D6429

illustra™ GFX™ PCR DNA
and Gel Band Purification Kit

GE Healthcare – UK Limited,
Buckinghamshire, UK

28-9034-70

Immu-mount™ mounting
medium

Thermo Fisher Scientific,
Waltham, MA

9990402

Isopropyl-β-DThiogalactopyranoside (IPTG)

BioShop, Burlington, ON

IPT001.5

Leupeptin

BioShop, Burlington, ON

LEU001

NucleoBond® Xtra Maxi

Machery-Nagel GmBH & Co.,
Duren, Germany

740714.50

Sodium Fluoride (NaF)

Signma-Aldrich, St. Louis, MO

S7920

Paraformaldehyde (PFA)

Thermo Fisher Scientific,
Whitby, ON

AC416780030

Pierce™ Glutathione Agarose

Thermo Fisher Scientific,
Rockford, IL

16100

Pierce™ Magnetic Protein A/G
Beads

Thermo Fisher Scientific,
Rockford, IL

88803

Penicillin (10,000 U/ml)
streptomycin (10 mg/ml)
solution

Thermo Fisher Scientific,
Rockford, IL

15140-122

Pepstatin

BioShop, Burlington, ON

PEP605

Phenylmethylsulfonylfluoride
(PMSF)

BioShop, Burlington, ON

PMS123
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Reagents and materials

Source

Catalogue No.

Polyethyleneimine, Linear 25
kDa (PEI)

Polysciences, Warrington, PA

23966

QIAprep® Spin Miniprep Kit

Qiagen, Hildon, Germany

27106

Rat tail collagen I

Corning, Bedford, MA

35426

Triiodothyronine (T3)

Sigma-Aldrich, St. Louis, MO

T6397

Triton X-100

EMD, Darmstadt, Germany

Trypsin (0.25%) with 0.02%
ethylenediaminetetraacetic acid
(EDTA)

Thermo Fisher Scientific,
Rockford, IL

25200-072

Trypsin (2.5%)

Life Technologies, Carlsbad,
CA

15090-046

Tween-20

Amresco, Solon, OH

Amicon Centrifugal Filters
(30K)

Millipore, Billerica, MA

Axygen® 1.5-ml Eppendorf
tubes

Corning, Bedford, MA

BioLite™ T25-cm2 Fasts, Cell
Culture Treated

Thermo Fisher Scientific,
Rockford, IL

130189

BioLite™ T75-cm2 Fasts, Cell
Culture Treated

Thermo Fisher Scientific,
Rockford, IL

130190

BioLite™ T175-cm2 Fasts, Cell
Culture Treated

Thermo Fisher Scientific,
Rockford, IL

130191

Blue Ray Film (8x10-in)

VWR Scientific, Radnor, PA

CA11006-128

Cellstar tissue culture dishes,
100-cm

VWR Scientific, Radnor, PA

82050-916

Conical tubes, 15-ml

Sarstedt, Numbrecht, Germany

62.554.205

Conical tubes, 50-ml

Sarstedt, Numbrecht, Germany

62.547.205

CATX-1568

0777
UFC803008
10011-700
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Reagents and materials

Source

Catalogue No.

EVOS FL Auto Imaging
System

Life Technologies, Carlsbad,
CA

AMAFD1000

Falcon™ cell strainer, 70-µm
pore size

Thermo Fisher Scientific,
Rockford, IL

CA21008-952

Greiner Bio-One 24-well cell
culture plates

VWR Scientific, Radnor, PA

Imaging dishes, µ-Chemotaxis
slides

Ibidi, Madison, WI

Immobilon polyvinylidene
difluoride (PVDF) transfer
membranes, 0.45-µm pore size

Millipore, Billerica, MA

Nunclon™ 4-well MultiDishes

VWR Scientific, Radnor, PA

Teflon cell scraper

Thermo Fisher Scientific,
Waltham, MA

Tissue homogenizer (TissueTearer)

Biospec Products Inc.,
Bartlesville, OK

VersaDoc Imaging System

Bio-Rad Laboratories Inc.,
Hercules, CA

82050-892
80326

IPVH00010
CA62407-068
08-100-240
Model 985370
170-8280
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2.2

Antibodies

Antibodies, their dilutions and sources are listed in Table 2.2.
Table 2.2: Antibodies
Antibodies *
Rabbit mAb anti-β-arrestin 1

Mouse mAb anti-FLAG

Rabbit pAb anti-FLAG

Dilution a,b
IB: 1:1000
IP: 1:200
IF: 1:1000
IB: 1:5000
IP: 2 µg

Source

Catalogue No.

Cell Signalling,
Pickering, ON

12697S

Sigma-Aldrich, St.
Louis, MO

F1804

Sigma-Aldrich, St.
Louis, MO

F7425
ADI-CSA-335E

Mouse mAb anti-GAPDH

IB: 1:5000

Enzo Life Sciences,
Farmingdale, NY

Mouse mAb anti-ILK

IB: 1:1000

BD Transduction
Laboratories, Lexington,
KY

Rabbit pAb anti-mCherry

IF: 1:1000

Novus Biologicals,
Littleton, CO

Chicken mAb anti-V5

IF: 1:500

Abcam, Toronto, ON

Ab9113

IB: 1:1000

Invitrogen, Carlsbad,
CA

R960CUS

Mouse mAb anti-V5

IP: 2 µg

611802

NBP2-25157

AlexaFluor™ 488conjugated goat anti-mouse
pAb IgG (H+L)

IF: 1:500

Life Technologies,
Carlsbad, CA

A11001

AlexaFluor™ 594conjugated goat anti-chicken
pAb IgG (H+L)

IF: 1:500

Life Technologies,
Carlsbad, CA

A11012

AlexaFluor™ 555conjugated goat anti-rabbit
pAb IgG (H+L)

IF: 1:500

Life Technologies,
Carlsbad, CA

A21428
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Dilution a,b

Source

Catalogue No.

Horseradish peroxidase
(HRP)-conjugated goat antimouse pAb IgG (H+L)

IB: 1:5000

Jackson
ImmunoResearch, West
Grove, PA

115-038-003

Horseradish peroxidase
(HRP)-conjugated goat antirabbit pAb IgG (H+L)

IB: 1:5000

Jackson
ImmunoResearch, West
Grove, PA

111-038-003

Antibodies *

*

mAb = monoclonal antibody; pAb = polyclonal antibody

a

IB = Immunoblot; IF = Immunofluorescence microscopy; IP =
Immunoprecipitation

b

IB: diluted in 1× TBST
IF: diluted in 1× PBS containing 5% goat serum
IP: diluted into 500 µl RIPA buffer

c

IB: diluted in 1× TBST containing 5% skim milk
IF: diluted in 1× PBS containing 1% goat serum
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2.3

Primers
Table 2.3: Sequences of primers used to generate β-arrestin 1 mutants

Plasmids

Primer

Primer sequence *

3A (I376A,
V377A, F378)

Forward HindIII

5’- ATGCAAGCTTCCATGGGCGACAAAGGGAC
ACG - 3’

Δ7 (Δ175-177,
Δ181-184)

Reverse BamHIFLAG tag

5’ – AGCTGGATCCCTAGGCGTCATCATCGT
CCTTGTAGTCTCTGTTGTTGAGGTG - 3’

Forward HindIII

5’- ATGCAAGCTTCCATGGGCGACAAAGGGAC
ACG - 3’

Reverse_p44_
NotI- FLAG tag

5’- GGATGCGGCCGCCTAGGCGTCATCATC
GTCCTTGTAGTCAACTTCCCGATGTGGGGG
C - 3’

Forward HindIII

5’- ATGCAAGCTTCCATGGGCGACAAAGGGAC
ACG - 3’

Reverse_N-term_
NotI- FLAG tag

5’- GGATGCGGCCGCCTAGGCGTCATCATC
GTCCTTGTAGTCATATTGAACCTTCCGGAT
GAC - 3’

Forward_C-term_
HindIII

5’- ATGCAAGCTTCCATGGAGACCACCAGACA
GTTC - 3’

Reverse NotIFLAG tag

5’- GGATGCGGCCGCCTAGGCGTCATCATCG
TCCTTGTAGTCTCTGTTGTTGAGGTGTGGAG
AGCC - 3’

Forward HindIII

5’- ATGCAAGCTTCCATGGGCGACAAAGGGAC
ACG - 3’

Reverse_1-350_
NotI- FLAG tag

5’- GGATGCGGCCGCCTAGGCGTCATCATCG
TCCTTGTAGTCGGTAAAGGGCAGTTCCACAG
C - 3’

R169E
P44 (1-365)

N-domain
(1-173)

C-domain
(186-419)

1-350

* Restriction enzyme sites are underlined; FLAG-tag is bolded.
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2.4

Vectors

Vectors encoding the indicated proteins are listed in Table 2.4.
Table 2.4: Vectors
Plasmid

Species

Plasmid backbone

Reference

FLAG-β-arrestin 1:
wild-type

Rattus norvegicus

pCMV5

Ferguson et al. 1996

FLAG-β-arrestin 1:
I376A, V377A,
F378 (3A)

R. norvegicus

pcDNA3.1

This study

FLAG-β-arrestin 1:
R169E

R. norvegicus

pcDNA3.1

This study

FLAG-β-arrestin 1:
Δ175-177, Δ181184 (Δ7)

R. norvegicus

pcDNA3.1

This study

FLAG-β-arrestin 1:
1-365 (p44)

R. norvegicus

pcDNA3.1

This study

FLAG-β-arrestin 1:
1-173 (N-domain)

R. norvegicus

pcDNA3.1

This study

FLAG-β-arrestin 1: R. norvegicus
186-418 (C-domain)

pcDNA3.1

This study

FLAG-β-arrestin 1:
1-350

R. norvegicus

pcDNA3.1

This study

V5-ILK: wild-type

Homo sapiens

pcDNA3.1

Novak et al. 1998

V5-ILK: 67-452

H. sapiens

pcDNA3.1

Vespa et al., 2005

V5-ILK: 1-192

H. sapiens

pcDNA3.1

Vespa et al., 2005

V5-ILK: E359K

H. sapiens

pcDNA3.1

Novak et al. 1998

mCherry-V5-ILK:
wild-type

H. sapiens

pmCherry-C1

Ho et al. 2009

mCherry

Discosoma sp

pmCherry-C1

Clontech, Palo Alto,
CA, Catalogue No.
632524

GFP

Aequorea victoria

peGFP-C1

Clontech, Palo Alto,
CA, Catalogue No.
6084-1
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Plasmid

Species

Plasmid backbone

Reference

GST

Pseudomonas
aeruginosa I

pGEX-4T1

GE Healthcare BioSciences,
Mississauga, ON,
Catalogue No.
28954549

GST-β-arrestin 1

P. aeruginosa I
(GST)

pGEX-4T1

Nobles et al. 2007

R. norvegicus (βarrestin 1)
TRX

Escherichia coli

pET32b

Novagene, Millipore,
Billerica, MA,
Catalogue No.
69016

TRX-ILK

E. coli (TRX)

pET32b

Nakrieko et al. 2008a

H. sapiens (ILK)

2.5
2.5.1

Cell isolation and culture
Primary keratinocytes

Primary epidermal keratinocytes were isolated from 2-day-old CD-1 mice, following a
procedure described by Dagnino et al., (2010). The mice were sacrificed by CO2
inhalation, followed by immersion in 70% (v/v) ethanol. The skin of each mouse was
harvested, placed dermis side down in a 10-cm Petri dish containing 7.5 ml of freshly
diluted 0.25% (v/v) trypsin in phosphate-buffered saline (PBS), and incubated at 4⁰C for
24 hours. The trypsin was replaced with 7.5 ml of freshly-diluted 0.25% (v/v) trypsin and
the skins were incubated for 20-40 min at 37⁰C. The epidermis was then mechanically
separated from the dermis using sterile forceps and the epidermal tissues from several
mice were pooled into a 50-ml conical tube containing 1 ml/epidermis of keratinocyte
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growth medium (Ca2+-free EMEM supplemented with 8% (v/v) chelex resin-treated fetal
bovine serum (FBS), 100 U/ml penicillin, 100 µg/ml streptomycin, 74 ng/ml
hydrocortisone, 5 µg/ml insulin, 9.5 ng/ml cholera toxin, 5 ng/ml epidermal growth factor
(EGF), and 6.7 ng/ml triiodothyronine (T3)) and minced with sterile scissors. The tissues
were gently rocked at 37⁰C for 40 min, and the resulting cell suspension was filtered
through a 70-µm cell strainer to remove tissue debris. The number of trypan-blue
excluding cells in the resulting suspension was determined with a haemocytometer.
Keratinocytes were plated onto 100-mm tissue culture plates or 4-well cell culture dishes
at a density of 9x106 cells/58 cm2 or 3x105 cells/2 cm2, respectively, and cultured at 37⁰C
in a humidified atmosphere containing 5% (v/v) CO2. Twenty-four hours after plating,
cells were gently rinsed once with PBS and fresh keratinocyte growth medium was added
with subsequent medium changes every 48 hours. All experiments were conducted with
keratinocytes that had been cultured for 48-72 hours.

2.5.2

Immortalized mouse epidermal keratinocytes (iKT cells)

iKT cells are a spontaneously immortalized line of keratinocytes, originally isolated from
the epidermis of 2-day-old K14Cre;Ilkf/+ mice (Jackson et al., 2015). iKT cells were
cultured in keratinocyte growth medium at 37⁰C in a humidified atmosphere containing
5% (v/v) CO2. These cells were maintained in T175 cell culture flasks, and the culture
medium was replaced every two days. Cells were passaged when they reached 80%
confluency by gently rinsing the cell monolayer with Ca2+-free PBS, followed by
incubation with 5 ml of 0.25% trypsin with 0.02% (w/v) EDTA for 12-15 minutes at
37⁰C. When approximately 80% of cells had detached, based on microscope
examination, 10 ml of keratinocyte growth medium were added to inhibit trypsin activity.
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The resulting cell suspension was transferred to a 50-ml conical tube and centrifuged at
130 x g for 5 min at 22⁰C. The supernatant was removed, and the cell pellet was
resuspended in approximately 1 ml of keratinocyte growth medium. Ten-microliter
portions of the cell suspension were mixed with 10 µl of trypan blue solution. The
number of trypan-blue excluding cells in the cell suspension was determined with a
haemocytometer. For chemotaxis experiments, cells were seeded onto the observation
area of the Ibidi® µ-slides at a density of 18x104 cells/2 mm2, or onto a new T175 cell
culture flask at a 1:5 dilution for maintenance of cell stocks. All experiments were
conducted with cells that had reached approximately 80% confluency and had been
passaged no more than 12 times.

2.5.3

Immortalized mouse dermal fibroblasts (IMDF cells)

IMDF cells are a spontaneously immortalized line of dermal fibroblasts originally
isolated from 2-day-old CD-1 mice (Apostolova et al., 2002). They were cultured on
T175 cell culture flasks, with HyQ-DMEM-RS supplemented with 8% (v/v) FBS at 37⁰C
in a humidified atmosphere containing 5% (v/v) CO2. Cells were passaged when they
reached 80% confluency by gently rinsing the cell monolayer with Ca2+-free PBS,
followed by incubation with 3 ml of 0.25% trypsin with 0.02% EDTA for 1-2 minutes
(until about 80% of cells had detached based on microscopic examination). Six ml of
growth medium were added to inhibit trypsin activity and the resulting cell suspension
was transferred to a 50-ml conical tube and centrifuged at 130 x g for 5 minutes at 22⁰C.
The supernatant was removed, and the cell pellet was resuspended in 10 ml DMEM. Tenmicroliter portions of the cell suspension were mixed with 10 µl of trypan blue solution.
The number of trypan-blue excluding cells in this suspension was determined with a
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haemocytometer. For experiments, cells were seeded onto 6-cm plates at a density of
7.5x105cells/21cm2, or onto a new T75 cell culture flask at a 1:10 dilution for
maintenance of cell stocks. Experiments were conducted with cells that had reached
approximately 80% confluency and had been passaged no more than 15 times.

2.5.4

HaCaT, SCC-25 and HeLa cells

HaCaT immortalized keratinocytes, SCC-25 oral squamous carcinoma cells, and HeLa
cervical carcinoma cells were cultured on T175 cell culture flasks, with HyQ-DMEM-RS
supplemented with 8% (v/v) FBS at 37⁰C in a humidified atmosphere containing 5%
(v/v) CO2. Once cells reached 80% confluency, they were passaged following the same
protocol described for IMDF cells (section 2.5.3). For co-immunoprecipitation (co-IP)
experiments with endogenous proteins, HaCaT cells were seeded onto 100-mm plates at a
density of 5x104 cells/58 cm2. SCC-25 and HeLa cells were not counted; instead, they
were plated onto 100-mm plates at a 1:5 dilution or onto T175 at a 1:10 dilution for
maintenance of cell stocks. All experiments were conducted with cells that had reached
approximately 80% confluency and had been passaged no more than 16 times.

2.6

Purification of recombinant proteins

E. coli BL-21(DE3) bacteria transformed with pET32b plasmids encoding thioredoxin
(TRX) or TRX-ILK were used to inoculate 400 ml of 2xYT medium supplemented with
100 µg/ml ampicillin and cultured at 37⁰C with vigorous shaking until OD600 reached
0.6. At this time, isopropyl 1-thio-β-D-galactopyranoside (IPTG, 0.5 mM final) was added
to the culture, and the bacteria were incubated overnight at 18⁰C with vigorous shaking to
induce recombinant protein production. The bacteria were collected by centrifugation,
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resuspended in 10 ml of ice-cold lysis buffer (10 mM imidazole, 300 mM NaCl, 50 mM
NaH2PO4, pH 8.0, 1 mM PMSF, 1 µg/ml aprotinin, 1 µg/ml pepstatin, 1 µg/ml
leupeptin), lysed using a French press, and centrifuged to separate lysate from cell debris.
Bacterial lysates were then incubated with 1 ml of a 50% slurry of Ni-NTA resin with
end-over-end rotation for 60 min at 4⁰C, followed by centrifugation at 800 x g and
removal of the supernatant. The resin was then washed thrice with Wash buffer (40 mM
imidazole, 300 mM NaCl, 50 mM NaH2PO4, pH 8.0). Proteins were recovered by two 5ml sequential elutions with 5 ml Elution buffer (300 mM NaCl, 50 mM NaH2PO4, pH
8.0), containing 250 mM imidazole, and 500 mM imidazole for the first and second
elution, respectively. Eluted fractions were pooled and desalted using Amicon Ultra
centrifugal filter columns.
The vector encoding GST-β-arrestin 1 (plasmid #36918) was obtained from Addgene,
and was deposited as a gift from Robert Lefkowitz (Nobles et al. 2007). E. coli BL21(DE3) bacteria transformed with pGEX4T1-backbone plasmids encoding either GST
or GST-β-arrestin 1 fusion protein were used to inoculate 400 ml 2xYT media and
cultured at 37⁰C to an OD600 of 0.8. Recombinant protein expression was induced by
adding IPTG (0.1 mM final) and incubating the cultures for 3 hours at 37⁰C or overnight
at 17⁰C, for GST or GST-β-arrestin 1 production, respectively. The bacteria were
collected by centrifugation, suspended and lysed with 10 ml MTPBS lysis buffer (150
mM NaCl, 4 mM NaH2PO4, 16 mM Na2HPO4, 1% triton X-100, 1 mM PMSF, 1 µg/
aprotinin, 1 µg/ml pepstatin, 1 µg/ml leupeptin) using a French press, followed by
centrifugation to separate the lysate from cell debris. Bacterial lysates were then
incubated with 1 ml of a 50% Glutathione Agarose slurry with end-over-end rotation for
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45 min at 22⁰C, followed by centrifugation and removal of the supernatant. The resin was
washed thrice with MTPBS, and proteins were recovered by two sequential elutions with
5 mL of 10 mM reduced glutathione dissolved in MTPBS. Elution fractions were pooled
and desalted using Amicon Ultra centrifugal columns.
In order to concentrate the samples and exchange the buffer in which the proteins were
dissolved in, the purified recombinant proteins were first loaded into 5-ml Amicon
columns, and the columns were centrifuged at 4,000 x g for 5 min at 4⁰C to reduce the
volume to about 500 µl. To exchange the buffer, 4 ml of PBS (supplemented with 1 mM
PMSF, 1 µg/ml aprotinin, 1 µg/ml pepstatin, and 1 µg/ml leupeptin) were added to the
Amicon column, and centrifugation to reduce buffer volume was conducted as above.
This step was repeated once again. The final protein solution recovered from the column
(0.5-1.0 ml), in which the solvent was mostly PBS, was stored as single-use 20-µl
aliquots at -80⁰C until needed for experiments.

2.7

Construction

of

mammalian

expression

vectors

encoding β-arrestin 1 mutant proteins
pET28a bacterial expression vectors containing cDNAs encoding the β-arrestin 1 mutants
3A (I376A, V377A, F378), Δ7 (Δ175-177, Δ181-184), R169E and p44 (1-365) were a
generous gift from Dr. D.K. Kim, Sungkyunkwan University, South Korea (Kim et al.,
2015). These four mutant cDNAs were amplified by polymerase chain reaction (PCR)
using the primers listed in Table 2.4. The resulting amplicons were cloned into the
mammalian expression vector pcDNA3.1. The β-arrestin 1 deletion mutants 1-173 (Ndomain), 186-418 (C-domain) and 1-350 were also generated by PCR using a

45

mammalian expression vector encoding wild-type β-arrestin 1 as a template (generous
gift from Dr. Moshmi Bhattacharya, Western University; Ferguson et al., 1996). The
primers used introduced a HindIII restriction site on the 5’end of the amplicon, as well as
an N-terminal NcoI site which functions as a Kozak sequence. The “3’-oligonucleotide”
primers introduced a FLAG-tag sequence (DYKDDDDK), the stop codon, and NotI or
BamHI restriction site at the 3’end of the cDNA. The resulting PCR products were
digested with HindIII and NotI (or BamHI) and ligated into pcDNA3.1 digested with the
same enzymes. The resulting DNA plasmids were transformed into competent E. coli
DH5α, expanded, purified, and verified by dideoxy sequencing at the DNA Sequencing
Facility of the London Regional Genomics Centre.

2.8

Transient transfections

Primary keratinocytes and iKT cells were transiently transfected with plasmids listed in
Table 2.4, using polyethyleneimine (PEI), as previously described (Dagnino et al., 2010).
PEI solutions (1 mg/ml) were prepared by dissolving PEI in ddH2O at 60⁰C with constant
stirring, and the pH was adjusted to 7.0 with 0.1 M HCl. The solution was sterilized by
passage through a 0.22-µm pore-size filter and stored in single-use, 500-µl aliquots at 20⁰C. To transfect cells seeded onto a 100-mm cell culture dish, 8 µg of plasmid DNA,
24 µl of PEI solution and sterile 150 mM NaCl were combined to a total volume of 500
µl. For a single 2-cm2 well, 2 µg of plasmid DNA, 6 µl of PEI solution and filtersterilized 150 mM NaCl were combined to a total volume of 100 µl. The transfection
solution was briefly vortexed, followed by a 10-min incubation period at 22⁰C to allow
formation of DNA-PEI complexes. The DNA-PEI solution was then added dropwise to
the culture medium in the dishes and gently, but thoroughly mixed. The cells were
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cultured at 37⁰C in a humidified atmosphere containing 5% (v/v) CO2 for 4 h. The PEIcontaining medium was removed by aspiration, the cells were rinsed twice with PBS and
fresh keratinocyte growth medium was added. The cells were cultured for 26-28 h prior
to processing for immunofluorescence microscopy or lysate preparation.

2.9

Preparation of lysates for protein analysis

Cell cultures were rinsed with PBS and lysed by addition of 100-300 µl of
radioimmunopreciptation assay (RIPA) buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl,
1% NP-40, 0.5% sodium deoxycholate, 1mM PMSF, 1 µg/ml NaF, 1 µg/ml aprotinin,
1µg/ml pepstatin, 1 µg/ml leupeptin). The cells were gently scraped from the culture
dishes using a Teflon cell scraper, and this suspension was transferred to a 1.5-ml
microfuge tube. Lysates were incubated on ice for 20 min followed by centrifugation at
13,400 x g for 10 min at 4⁰C. The supernatant was then transferred to a clean microfuge
tube. To prepare tissue lysates, brain, heart, lungs and liver from 2-day-old CD-1 mice
were harvested. A small fragment of an individual tissue was placed in a 2-ml microfuge
tube containing 500 µl ice-cold RIPA buffer and homogenized using a hand-held tissue
homogenizer. To obtain epidermal and dermal lysates, the skin was harvested and placed
dermis side down in a 10-cm Petri dish containing 7 ml of Dispase II diluted in PBS (2.4
U/ml, final) and incubated for 1.5 h at 37⁰C. The epidermis and dermis were
mechanically separated with forceps, placed into separate 2-ml microfuge tubes
containing 200 µl ice-cold RIPA buffer and homogenized with a tissue homogenizer.
After homogenization, the samples were centrifuged at 13,400 x g for 10 min at 4⁰C to
remove tissue debris, and the lysates were transferred to clean microfuge tubes. The
protein concentrations of cell and tissue lysates were determined using Bradford protein
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quantification assays. For immunoblotting experiments, 15-100 µg lysate added to a 1.5ml microfuge tube were mixed with ¼ volume of 4x Laemmli buffer (1 M Tris-HCl pH
6.8, 20% SDS, 4 mg/ml bromophenol blue, 40% glycerol, 0.06 g/ml DTT). The samples
were heated for 8 min at 95⁰C prior to loading on denaturing polyacrylamide gels
(section 2.12).

2.10 Co-immunoprecipitation (co-IP) experiments
For co-IP experiments, lysate samples containing 750 µg-4 mg protein were incubated
with primary antibody (dilution indicated in Table 2.2, antibody indicated in individual
experiments) for 16 h at 4⁰C. Forty-microliters of Pierce™ protein A/G magnetic beads
were washed with 1-ml Wash buffer (PBS containing 0.05% (v/v) Tween-20),
resuspended in 20 µl Wash buffer, added to each protein sample and incubated for 1 h at
22⁰C with end-over-end rotation. The beads were thoroughly rinsed 5 times with 1 ml of
Wash buffer. Immune complexes were eluted by incubation with 40 µl of 1x Laemmli
buffer for 10 min at 22⁰C, and were resolved by denaturing polyacrylamide gel
electrophoresis (SDS-PAGE, section 2.12).

2.11 In vitro protein binding assays
For in vitro protein binding assays, 2 µg of each purified recombinant protein were mixed
in RIPA buffer and incubated for 1 h at 4⁰C, followed by immunoprecipitation with antiβ-arrestin 1 antibody, as described in section 2.10.

48

2.12 Denaturing polyacrylamide gel electrophoresis (SDSPAGE) and immunoblot analysis
Lysates and immune complexes were resolved by SDS-PAGE using 5% (w/v) stacking
and 10% (w/v) separating polyacrylamide gels. Proteins in the gel were transferred to
0.45-µm polyvinylidene fluoride (PVDF) membranes using a semi-dry transfer apparatus.
Membranes were blocked with 5% (w/v) non-fat milk diluted in Tris-buffered saline
containing 0.05% (v/v) Tween-20 (TBST, 100 mM Tris-HCl pH 7.5, 1.5 M NaCl) with
rocking for 1 h at 22⁰C. Membranes were rinsed twice with TBST, placed in a 50-ml
conical tube containing 5 ml primary antibody diluted in TBST (as per Table 2.2), and
incubated with rotation for 1 h at 22⁰C or 16 h at 4⁰C. Membranes were washed thrice
with TBST, 10 min per wash, followed by incubation with rotation in 50-ml conical tubes
containing 5 ml of HRP-conjugated secondary antibody (1:5000 v/v in TBST containing
5% (w/v) non-fat milk) for 1 h at 22⁰C. The membranes were washed five times with
TBST (10 min per wash). Amersham ECL Prime western blotting detection reagent was
added to the membranes and proteins were visualized using X-ray film or with a
VersaDoc Imaging System (Table 2.1).

2.13 Immunofluorescence microscopy
For microscopy analysis, cells cultured in 4-well dishes were fixed for 20 min at 22⁰C
with freshly diluted, ice-cold 4% paraformaldehyde (PFA) in PBS, and then washed
thrice with PBS. Cells were permeabilized with 300 µl of 0.01% (v/v) Triton X-100
diluted in PBS for 20 min at 22⁰C, and then washed thrice with PBS. The samples were
blocked with 500 µl of PBS containing 1% (w/v) non-fat milk and 1% (v/v) goat serum
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for 1 h at 22⁰C with rocking, and washed thrice with PBS, 10 min each time. Samples
were incubated with 300 µl of primary antibody diluted in PBS containing 5% (v/v) goat
serum with rocking for 1 h at 22⁰C (antibodies and their dilutions listed in Table 2.2).
Cells were washed with PBS four times, ten min each. Samples were incubated with 300
µl of AlexaFluor™ - conjugated secondary antibodies diluted in PBS containing 1% (v/v)
goat serum with rocking for 1 h at 22⁰C, protected from the light and washed thrice with
PBS, followed by a 10-min incubation with 500 µl Hoescht 33342 diluted in PBS (1
ng/µl), protected from the light. Finally, samples were washed thrice with PBS and 12mm glass coverslips were mounted onto the samples using Immu-mount mounting
medium and allowed to dry overnight, protected from light, at 22⁰C. Photomicrographs
were obtained with a Leica DMIRBE fluorescence microscope equipped with an OrcaER digital camera (Hamamatsu Photonics, Hamamatsu City, Japan), using Volocity 4.3.2
software (Improvision, Coventry, United Kingdom). Brightness and contrast in the
micrographs were adjusted uniformly with Photoshop CS6 software.

2.14 Chemotaxis assays
For chemotaxis assays, 6 µl of a 3x106 cells/ml iKT cell suspension were seeded onto the
observation area of Ibidi® chemotaxis µ-slides according to the manufacturer’s
instructions (Figure 2.1). Slides with cells were cultured inside a petri dish containing
tissues saturated with water to maintain a humid atmosphere and minimize evaporation.
Approximately 18 h after plating, the cells had adhered and spread, and the growth
medium was changed to serum-free EMEM supplemented with 1% (w/v) BSA. The cells
were cultured for 1 h at 37⁰C in a humidified atmosphere containing 5% (v/v) CO2. The
reservoirs on each side of the observation area were then filled with 60 µl of serum-free
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Figure 2.1. Ibidi µ-Slide Chemotaxis set-up.
(A) One slide has 3 chemotaxis chambers. Cells and slide were cultured in a petri dish
containing wet tissues to maintain a humidified atmosphere and prevent evaporation. (B)
Provided plugs were placed into ports C, D, E and F. Six µl of the cell suspension were
added to port A. Immediately following, the same pipet setting (6 µl) was used to aspirate
air from port B. To fill the reservoirs, plugs were placed into ports A, B, C, and D, and 65
µl of serum-free medium were added to port F. Plugs were moved from C and D to E and
F. 65 µl of serum-free medium were added to port C. To add the chemoattractant, 15 µl
of EGF (100 ng/µl) were added to port C. Following this, 15 µl of medium were aspirated
from port D. This step was repeated once more.
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EMEM (added to ports C and E, Figure 2.1). To generate an epidermal growth factor
gradient, 30 µl of a 100 ng/µl EGF solution in sterile, distilled water were added to the
left reservoir (added to port C, Figure 2.1), and 30 µl of medium were removed (removed
from port D, Figure 2.1), making the final concentration in the reservoir 50 ng/µl. The
cells were then imaged by time-lapse videomicroscopy for 8 h at 37⁰C in a humidified
atmosphere containing 5% (v/v) CO2 using an Invitrogen™ EVOS™ FL Auto Imaging
System. The cells were imaged once every 10 minutes, and each cell moved
approximately two cells lengths between images. From the images obtained, cells were
manually tracked using the Manual Tracking (version 1) plugin for ImageJ (Fiji) software
version 1.50i. The speed, accumulated and Euclidean (defined as a straight line between
the initial and the final position of a cell) distances, and x-axis forward migration index
(x-FMI) of each cell were calculated using the ImageJ Chemotaxis & Migration Tool
(version 1.01; Ibidi). The speed, accumulated and Euclidean distances, are presented as
the mean for each condition. In addition, the overall distribution pattern of the cell
velocities, accumulated and euclidean distances, and x-FMI was determined. For each,
the percentage of cells that scored into different intervals (as indicated in each
experiment) was calculated. For example, to analyze the overall distribution pattern of the
accumulated distances, the percent of cells that were scored into each of 5 intervals (0100, 101-200, 201-300, 301-400, and 401-500 µm) were determined.

2.15 Statistical analysis
For protein subcellular localization studies using immunofluorescence microscopy, each
biological replicate contained duplicate samples (i.e. two technical replicates, obtained
from duplicate culture wells). One hundred cells/sample (fifty cells/well), were counted

53

and scored based on subcellular localization of transfected proteins, as indicated in each
experiment.
For chemotaxis studies, 50-100 cells were tracked per condition in each biological
replicate. For all biological replicates, the speed, accumulated and euclidean distances,
and x-FMI of each individual cell were recorded. A two-tailed unpaired T-test was
performed to determine significance of the average speed, accumulated distance or
euclidean distance between the control and EGF conditions. A one-way analysis of
variance (ANOVA) with Tukey’s post-hoc test was performed to determine significance
between each set of intervals of the same condition (i.e. significance between the speed
intervals for the EGF condition, or the significance between the x-FMI intervals for the
control condition).
For the immunofluorescence microscopy experiments, a two-tailed unpaired T-test was
performed to determine significance between the double transfected and single
transfected cells for each subcellular localization. A one-way ANOVA with Tukey’s
post-hoc test was performed to determine significance between the subcellular
localization of each β-arrestin 1 mutant. GraphPad Prism version 6 was used for
statistical analyses and significance was set at p<0.05. All results shown are
representative of at least three separate experiments conducted with different primary
keratinocyte isolates or different cell line passages.
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Chapter 3

3

Results

3.1

Abundance of β-arrestin 1 and ILK in the epidermis

To begin to address the role of ILK and β-arrestin 1 in the epidermis, I first sought to
compare their relative abundance in this tissue with that in other mouse organs and
several epithelial cell lines. To this end, I prepared protein lysates and analyzed them by
immunoblot using antibodies against ILK and β-arrestin 1. ILK was present in the
epidermis, but at lower levels compared to those found in brain, heart, lung, liver, and
dermis (Figure 3.1A). The abundance of ILK in cultured primary mouse keratinocytes
was comparable to that found in iKT cells [a spontaneously immortalized mouse
epidermal keratinocyte line previously isolated in my laboratory (Jackson et al., 2015)],
as well as in a variety of human epithelial cell lines tested, including HeLa cervical
carcinoma, HaCaT spontaneously immortalized human keratinocytes, SCC-25 tongue
epithelial carcinoma, and MDA-MB-231 breast carcinoma cells (Figure 3.1B).
I was also able to detect -arrestin 1 in several mouse tissues and organs, although its
relative levels appeared to vary to a greater extent than those of ILK. Specifically, arrestin 1 was most abundant in brain and lung, whereas heart, liver, dermis and
epidermis showed lower levels of this protein (Figure 3.1A). β-Arrestin 1 was also
detected at low levels in cultured primary mouse keratinocytes and iKT cells, whereas it
was more abundant in human HeLa, HaCaT, and SCC-25 cells (Figure 3.1B). As
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Figure 3.1. ILK and β-arrestin 1 are expressed in the epidermis and cultured
keratinocytes.
Two-day-old mice were dissected and organs harvested. The specified amount of mouse
tissue lysates (A) or cell lysates (B) were subjected to western blot analysis with
antibodies against ILK and -arrestin 1. GAPDH was used to normalize for protein
loading. Blot exposure times are indicated to better illustrate differences in protein
abundance. Abbreviations: KC, primary keratinocytes.
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previously reported, -arrestin 1 was present at high levels in MDA-MB-231 cells
(Figure 3.1B; Li et al., 2009). These results confirm that ILK and -arrestin 1 are widely
expressed in tissues and organs, and show that in the epidermis both proteins are present
at relatively low levels.

3.2

Interaction of

ILK and β-arrestin 1 in cultured

keratinocytes
ILK has been reported to associate with -arrestins at the base of primary cilium in
several cell lines, where it is thought to modulate hedgehog protein signaling via
Smoothened receptors (Barakat et al., 2013). To investigate if ILK and β-arrestin 1
associate in primary mouse keratinocytes, I exogenously expressed ILK tagged with V5
or

both

V5

and

mCherry,

and

FLAG-tagged-β-arrestin

1.

I

isolated

V5

immunoprecipitates, and after immunoblot analysis, I observed the presence of FLAG-arrestin 1 (Figure 3.2). Reciprocally, I found V5-ILK or V5-mCherry-ILK in FLAG-βarrestin 1 immune complexes (Figure 3.2). This indicates that ILK and β-arrestin 1 can
form complexes in keratinocytes, when exogenously expressed. Further, the presence of
the larger mCherry tag on ILK did not interfere with the formation of these complexes.
To confirm the interactions I observed with exogenously expressed proteins, I next
investigated if endogenous β-arrestin 1 and ILK could also be found in complexes in
keratinocytes. For these experiments, I first isolated -arrestin 1 immune complexes from
HaCaT keratinocytes, in which ILK and -arrestin 1 levels are higher than in primary
mouse keratinocytes, and was able to detect endogenous ILK (Figure 3.3). When this
experiment was repeated with primary mouse keratinocytes, it was not possible to
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Figure 3.2 Interaction between exogenously expressed ILK and β-arrestin 1 in
keratinocytes.
Primary mouse keratinocytes cultured in low-Ca2+ EMEM were transfected with vectors
encoding V5-tagged ILK, V5-tagged mCherry-ILK, and FLAG-tagged β-arrestin 1.
Twenty-eight hours after transfection, cell lysates were prepared (750 µg protein/sample)
and immunoprecipitated with anti-FLAG or anti-V5 antibodies, as indicated, or an
unrelated mouse or rabbit IgG. Immune complexes were analyzed by immunoblot with
the indicated antibodies. In parallel, samples of cell lysates (20 µg/sample) were analyzed
by immunoblot with antibodies against FLAG and V5. GAPDH was used to normalize
for protein loading.
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Figure 3.3. Interaction between endogenous ILK and β-arrestin 1 in HaCaT
keratinocytes.
HaCaT cell lysates were prepared (4,000 µg protein/sample) and immunoprecipitated
with anti-β-arrestin 1 or an unrelated rabbit IgG, and analyzed by immunoblot with the
indicated antibodies. As a positive control, lysates from primary keratinocytes transfected
with vectors encoding V5-tagged ILK and FLAG-tagged β-arrestin 1 were prepared (750
µg/sample) and immunoprecipitated with anti-β-arrestin 1. In parallel, samples of HaCaT
cell lysates (100 µg/sample) and transfected primary keratinocyte lysate (10 µg/sample)
were analyzed by immunoblot with antibodies against ILK and β-arrestin 1. GAPDH was
used to normalize for protein loading. Abbreviations: KC, primary keratinocytes.
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efficiently isolate arrestin 1 immune complexes, likely due, at least in part, to its relative
scarcity in these cells. Therefore, I sought to determine if exogenously expressed arrestin 1 could associate with endogenous ILK. I transfected primary mouse
keratinocytes with vectors encoding both FLAG-tagged -arrestin 1 and V5-tagged ILK.
I isolated -arrestin 1 immune complexes, and was able to detect endogenous ILK, as
well as V5-tagged exogenous ILK. The latter is distinguishable from the former by the
slightly lower mobility associated with the presence of the V5 tag (Figure 3.3). Together,
these experiments demonstrate biochemically that endogenous -arrestin 1 can form
complexes with ILK in keratinocytes.

3.3

Direct binding of ILK to β-arrestin 1

To examine whether β-arrestin 1 and ILK directly bind to each other, I analyzed the
ability of bacterially produced recombinant TRX-V5-tagged ILK to form complexes with
GST-tagged β-arrestin 1, using in vitro binding assays. After purification and desalting, I
analyzed the recombinant proteins by denaturing gel electrophoresis, followed by
visualization using Coomassie R-250 staining. I confirmed the presence of GST and TRX
proteins, which served as controls in these experiments. The GST--arrestin 1
preparation was mainly composed of full-length protein with the expected molecular
mass of approximately 75 kDa, with very small contributions of smaller, likely partiallength products (Figure 3.4A). Recombinant TRX-ILK was also present as a mixture of
the full-length protein, with an approximate molecular mass of 70 kDa, together with
several partial-length species (Figure 3.4A). Importantly, with the use of the TRX tag I
was able to produce soluble, full-length ILK for in vitro binding assays.
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Figure 3.4. Direct interaction between purified GST-β-arrestin 1 and TRX-ILK.
(A) Purified bacterially produced recombinant proteins (10 µg/sample) were resolved by
denaturing gel electrophoresis and visualized using Coomassie R-25. (B) Bacterially
produced GST--arrestin 1 and TRX-ILK (2 µg of each protein) were allowed to interact,
followed by immunoprecipitation with anti-β-arrestin 1. Incubation of TRX and GST-βarrestin 1, as well as GST and TRX-ILK, followed by immunoprecipitation with anti-βarrestin 1, were used as negative controls. Lysate from keratinocytes transfected with
vectors

encoding

FLAG-tagged

β-arrestin

1

and

V5-tagged

ILK

were

immunoprecipitated with anti-β-arrestin 1 as a positive control. Immune complexes were
analyzed by immunoblot with the indicated antibodies. Lanes labelled “input/lysate”
contain 100 ng each of the indicated recombinant proteins, and 20 µg of the transfected
keratinocyte lysate.
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I then incubated GST--arrestin 1 in the presence of TRX or TRX-ILK and isolated arrestin 1 immune complexes. In parallel, as a positive control, I isolated -arrestin 1
immune complexes from lysates obtained from keratinocytes overexpressing V5-tagged
ILK and FLAG-tagged -arrestin 1. Immunoblot analysis revealed the presence of TRXILK and V5-ILK, but not TRX alone, in -arrestin 1 immunoprecipitates (Figure 3.4B)
This indicates that -arrestin 1 and ILK can associate directly with each other, and that
this association does not require post-translational modifications of either protein.

3.4

Subcellular localization of ILK and β-arrestin 1

Having established the presence of ILK-β-arrestin 1 complexes in epidermal
keratinocytes, I next examined the subcellular distribution of both proteins. To this end, I
transiently transfected primary keratinocytes with V5-tagged mCherry-ILK and FLAGtagged β-arrestin 1, and processed the cells for immunofluorescence microscopy. βArrestin 1 was distributed throughout the cytoplasm in all cells. However, 56% of
transfected cells also exhibited -arrestin 1 immunoreactivity in regions along the
membrane that appeared to be associated with cell protrusions (Figure 3.5A,D; Appendix
A).
Consistent with previous findings in our laboratory (Vespa et al., 2005; Ho et al., 2009),
ILK immunoreactivity was found throughout the cytoplasm in all cells, and in addition,
ILK localized to membrane regions associated with cell protrusions in 60% of transfected
cells (Figure 3.5B,E; Appendix A). When -arrestin 1 was jointly expressed with
exogenous ILK, a significant increase in β-arrestin 1 localized to cell protrusions in 62%
of co-transfected cells was observed, suggesting a small, but significant effect of ILK on
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Figure 3.5. Co-localization of β-arrestin 1 and ILK in keratinocytes.
Primary mouse keratinocytes were transfected with FLAG-tagged -arrestin 1 and/or V5tagged mCherry-ILK. Twenty-eight hours after transfection, the cells were fixed with 4%
(w/v) paraformaldehyde and processed for immunofluorescence microscopy using
antibodies against FLAG and V5 to visualize -arrestin 1 and ILK, respectively. Hoescht
33342 was used to visualize DNA. Representative fluorescence micrographs depicting arrestin 1 (A), ILK (B), or both (C). One hundred cells were counted and the number of
-arrestin 1 -/+ ILK cells (D) or ILK -/+ -arrestin 1 cells (E) that exhibited localization
throughout the cytoplasm (termed cytoplasm only; C) or cytoplasmic localization with
additional localization along membrane extensions (termed cytoplasm+extensions; C+E)
were scored. Results are expressed as a mean +/- SEM (n=3). *p<0.05 (unpaired T-Test)
relative to single transfected cells. Bar, 16 m; Insets, higher magnification and exposure
time to highlight the localization of indicated proteins along membrane extensions in
cytoplasm+extensions category, or lack of localization of indicated proteins in the
cytoplasm only category.
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the ability of -arrestin 1 to localize to these areas (Figure 3.5C-E; Appendix A). All cells
in which ILK was observed at the membrane showed β-arrestin 1 colocalization (Figure
3.5C; Appendix A).

3.5

ILK regions involved in interactions with β-arrestin 1

To identify the regions of ILK that are necessary for its interactions with β-arrestin 1, I
exogenously expressed a series of V5-tagged ILK mutants, together with wild-type
FLAG-tagged β-arrestin 1 in primary mouse keratinocytes. I then isolated V5 immune
complexes, and probed them for the presence of -arrestin 1. I tested two ILK deletion
mutants, 1-192 and 67-452, as well as a form of ILK containing the point mutation
E359K (Table 3.1; Figure 3.6A).
Table 3.1: ILK mutants
ILK mutant

Regions missing/ mutated

Functional consequence

1-192

Pseudokinase domain

67-452

ANK 1 and 2

E359K

Pseudokinase domain

Loss of:
 Focal adhesion localization
 Paxillin and parvin binding
Loss of:
 Focal adhesion localization
 Nuclear localization
 Cell-cell junction localization
 PINCH binding
Loss of:
 Focal adhesion localization
 Paxillin and parvin binding

ILK 1-192 is a C-terminus truncation mutant, which contains all ankyrin repeats, but
lacks the pseudokinase domain. This mutant is unable to localize to focal adhesions, and
does not bind to paxillin or parvins, although it can bind to PINCH, another focal
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Figure 3.6. Regions of ILK that interact with β-arrestin 1.
(A) Schematic representation of V5-tagged ILK mutants. Domains in wild-type ILK
include the five ankyrin repeats (1-5), pleckstrin homology (PH)-like domain and kinaselike domain (KLD). Wild-type is indicated as WT. Asterisk indicates mutation E359K.
(B) Primary mouse keratinocytes were transfected with vectors encoding V5-tagged ILK
mutants and FLAG-tagged β-arrestin 1. The negative sign (-) indicates transfection with
an empty pcDNA3.1 vector. Twenty-eight hours after transfection, cell lysates were
prepared (750 µg/sample) and immunoprecipitated with anti-V5 or an unrelated mouse
IgG. Immune complexes were analyzed by immunoblot with the indicated antibodies. In
parallel, samples of the cell lysates (20 µg/sample) were analyzed by immunoblot with
antibodies against FLAG and V5. GAPDH was used to normalize for protein loading.
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adhesion protein, and to ELMO2 (Wu and Dedhar, 2001; Ho et al., 2009). I observed that
this mutant is also able to interact with -arrestin 1 (Figure 3.6B).
ILK 67-452 is missing the first two N-terminal ankyrin repeats, rendering it unable to
interact with PINCH or to localize to focal adhesions (Li et al., 1999). Furthermore, this
mutant lacks the nuclear localization domain, and it is not found at cell-cell junctions in
differentiated keratinocytes (Vespa et al., 2005; Nakrieko et al., 2008b). I observed the
presence of β-arrestin 1 in ILK 67-452 immune complexes, although the abundance of βarrestin 1 observed in association with this ILK mutant was substantially lower than
when in association with the wild-type. Because wild-type and ILK 67-452 were
expressed at similar levels, these observations indicate that the first 67 amino acids in
ILK contain critical structural determinants for optimal binding to -arrestin 1.
ILK E359K contains a point mutation within the pseudokinase domain that prevents ILK
localization to focal adhesions (Nikolopoulos and Turner, 2002). This mutation also
impairs ILK from binding to many other proteins, including parvins and paxillin, but not
ELMO2 (Wu and Dedhar, 2001; Ho et al., 2009). Similar to wild-type ILK, the E359K
mutant form effectively bound to -arrestin 1 (Figure 3.6B). Thus, the C-terminal half of
ILK is dispensable for the interactions with -arrestin 1, whereas regions that include the
first two ankyrin repeats and the nuclear localization domain are essential.

3.6

β-arrestin 1 domains involved in interactions with ILK

Three main functional regions have been identified in -arrestins. There is the N-domain
(residues 1-173), which is linked to the C-domain (residues 186-418) through a 12-
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residue long “inter-domain hinge” (IDH) region (Gurevich and Gurevich, 2013). Using a
similar approach as described above (section 3.5), I exogenously expressed a series of βarrestin 1 deletion mutants, combined with proteins containing point mutations, to map
the regions required for association with ILK. The first three mutants I investigated were
R169E, which contains a point mutation within the N-domain causing destruction of the
salt bridge between the N- and C-domain (Kovoor et al., 1999); 3A (I387A, V388A and
F389A), which contains a triple alanine substitution in place of three hydrophobic
residues within the three-element region (Vishnivetskiy et al., 2000); and Δ7, which
contains a deletion of seven residues within the inter-domain hinge (Δ175-177, Δ181184) (Song et al., 2006) (Figure 3.7A). The first two mutations maintain β-arrestin 1 in an
“open” conformation. This occurs through disruption of the two important intramolecular interactions that hold the N- and the C-domains of β-arrestin 1 in place. In
contrast, the third mutation promotes maintenance of β-arrestin 1 in a basal “closed”
conformation (Table 3.2; Kim et al., 2015).
Table 3.2: β-arrestin 1 mutants
β-arrestin 1
mutant

Regions
missing/mutated

Functional
conformation

Functional consequence

R169E

Polar core

Open

Higher affinity for unactivated GPCRs

Δ7

Inter-domain
hinge

Closed

Higher affinity for microtubules and
lower affinity for GPCRs

3A

Three-element
region

Open

Higher affinity for unactivated GPCRs

1-365

C-tail

Open

Higher affinity for unactivated GPCRs

1-350

C-domain

Unknown

Unknown
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1-173

C-domain

Unknown

Unknown

186-418

N-domain

Unknown

Unknown

Vectors encoding the above-mentioned FLAG-tagged β-arrestin 1 mutants were
transiently transfected along with wild-type V5-tagged ILK into primary mouse
keratinocytes. Analysis of V5 immune complexes revealed the presence of -arrestin 1
R169E and Δ7, indicating that the interaction between ILK and -arrestin 1 can occur
irrespective of whether -arrestin 1 adopts an “open” or “closed” conformational state
(Figure 3.7B). I also observed the presence of -arrestin 1 3A in ILK immune complexes,
although the abundance of this mutant observed in association with ILK was consistently
lower than that of the wild-type protein. Because wild-type and -arrestin 3A were
expressed in the cells at similar levels, these observations suggest that Ile387, Val388 and
Phe389 together are important contributors to the interaction of -arrestin 1 with ILK
(Figure 3.7B).
To complement this analysis, I also investigated the ability of several -arrestin 1
deletion mutants to associate with ILK. These mutants were -arrestin 1 1-350, 1-365,
both of which contain the inter-domain hinge and portions of the C-domain, 1-173 (Ndomain only) and 186-418 (C-domain only) (Figure 3.8). I first noted a large variation in
the abundance of these different mutants when expressed in keratinocytes (Figure 3.8).
Specifically, -arrestin 186-418, which contains all of the C-domain, was very abundant.
In contrast, the levels of the -arrestin 1 mutants containing residues 1-173 (N-domain
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Figure 3.7. Different conformational arrangements of β-arrestin 1 that interact with
ILK.
(A) Schematic representation of FLAG-tagged β-arrestin 1 mutants. Domains in βarrestin 1 include the N-domain and C-domain connected by an inter-domain hinge
(IDH). Wild-type is indicated as WT. Asterisks indicate point mutations which maintain
β-arrestin 1 in an “open” conformation, and “X” indicates a group of deleted amino acids
maintaining β-arrestin 1 in a closed conformation. (B) Primary mouse keratinocytes were
transfected with vectors encoding FLAG-tagged β-arrestin 1 mutants and V5-tagged ILK.
Twenty-eight hours after transfection, cell lysates were prepared (750 µg/sample) and
immunoprecipitated with anti-V5 or an unrelated mouse IgG. Immune complexes were
analyzed by immunoblot with the indicated antibodies. In parallel, samples of cell lysates
(20 µg/sample) were resolved by SDS-PAGE and analyzed by immunoblot with
antibodies against FLAG and V5. GAPDH was used to normalize for protein loading.
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Figure 3.8. Domains of β-arrestin 1 that interact with ILK.
(A) Schematic representation of FLAG-tagged β-arrestin 1 deletion mutants. Domains in
β-arrestin 1 include the N-domain and C-domain connected by an inter-domain hinge
(IDH). Wild-type is indicated as WT. Numbers on the right side indicate amino acid
residues comprising each mutant. (B) Primary mouse keratinocytes were transfected with
vectors encoding FLAG-tagged β-arrestin 1 mutants and V5-tagged ILK. Twenty-eight
hours after transfection, cell lysates were prepared (750-2,000 µg/sample) and
immunoprecipitated with anti-V5 or an unrelated mouse IgG. Immune complexes were
analyzed by immunoblot with the indicated antibodies. In parallel, samples of cell lysates
(20-100 µg/sample) were resolved by SDS-PAGE and analyzed by immunoblot with
antibodies against FLAG and V5. GAPDH was used to normalize for protein loading,
white arrows indicate mutant protein band and asterisks indicate non-specific IgG bands.
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only), 1-350, and 1-365 were substantially lower, and were only detected on
immunoblots upon longer exposure times (Figure 3.8). These observations are consistent
with the concept that sequences that include amino acid residues 365-418 are likely
important contributors to -arrestin 1 stability.
My analysis of ILK immune complexes readily revealed the presence of -arrestin 1 186418, confirming that the C-domain is capable of associating with ILK (Figure 3.8). I was
also able to detect low levels of the -arrestin 1 mutants 1-173 and 1-365 in ILK immune
complexes, although my experiments do not allow me to distinguish whether these
apparently poor interactions are due to inefficient association with ILK or poor protein
expression. In stark contrast, ILK immune complexes contained levels of -arrestin 1 1350 that were comparable to those of the wild-type proteins (Figure 3.8). Together with
the observed association of ILK and -arrestin 1 186-418, these observations suggest that
regions encompassed between amino acid residues 186 and 350 may play key roles in the
ability of -arrestin 1 to bind ILK.

3.7

Subcellular distribution of β-arrestin 1 mutant proteins
in the absence and presence of ILK

To investigate the subcellular distribution of the -arrestin 1 mutants, and to determine
the effect of ILK on this distribution, I transiently transfected primary keratinocytes with
wild-type or the mutant forms of FLAG-tagged -arrestin 1 described above, together
with V5-tagged mCherry-ILK. I evaluated 100 transfected cells for each experimental
condition in each biological replicate, and the fraction of cells with proteins localized
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within the cytoplasm as well as along membrane extensions (C+E), only within the
cytoplasm (C) or only in the nucleus (N) was scored.
When expressed in the absence of ILK, both -arrestin 1 R169E and Δ7 exhibited
subcellular localization patterns similar to those of the wild-type protein. Specifically,
these β-arrestin 1 proteins were found in the cytoplasm of all transfected cells, but they
were also observed at membrane protrusions in 57% (R169E) and 54% (Δ7) of the cells
(Figures 3.9A,C and 3.10A,C; Table 3.4; Appendix B). In the presence of ILK, both
R169E and Δ7, colocalized with ILK at membrane protrusions in 59% and 57% of cells,
respectively (Figures 3.9B,C and 3.10B,C; Table 3.4; Appendix B). This pattern of colocalization was comparable to that observed with wild-type -arrestin 1 in the presence
of ILK, in the sense that all the cells in which ILK was found at the membrane showed
R169E and Δ7 colocalization at that site (Figures 3.9B,D and 3.10B,D; Tables 3.4 and
3.5; Appendix B). These results complement the data obtained from coimmunoprecipitation experiments illustrating a strong interaction between ILK and each
of these mutants, which was similar to the interaction observed between ILK and wildtype -arrestin 1 (section 3.6; Figure 3.7).
-Arrestin 1 3A was observed at membrane protrusions in only 39% of transfected cells,
significantly less than the wild-type form (Figures 3.11A,C; Table 3.3; Appendix B).
Remarkably, this mutant shows nuclear localization in 20% of transfected cells, which
was not observed with the wild-type protein (Figures 3.11A,C; Table 3.3; Appendix B).
In the presence of exogenous ILK, there was a small, but significant increase in the
fraction of cells that exhibited β-arrestin 1 3A nuclear localization; however, ILK
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Table 3.3: Summary of β-arrestin 1 mutants 3A, 1-365 and 1-173 subcellular
distribution in the absence and presence of ILK.

1-173

ILK

Cytoplasm +
Extensions (%)
39 _+ 1.5
41 _+ 1.0

41 _+ 2.1 *
33 _+ 1.7

20 _+ 0.6 *
26 _+ 0.7

4 _+ 1.5
3 _+ 0.9

15 _+ 2.6
32 _+ 3.8 *

17 _+ 2.7
33 _+ 3.5 *

3 _+ 1.2
1 _+ 0.7

45 _+ 4.3
37 _+ 4.1

52 _+ 4.0

+
-

1-365

Nucleus
only (%)

+
-

3A

Cytoplasm
only (%)

+
-

Mutant

62 _+ 4.2

Perinuclear
(%)
0
0
64 _+ 3.0
32 _+ 3.2 *
0
0

Table 3.4: Summary of β-arrestin 1 wild-type (wt), R169E, ∆7, 186-418 and 1-350
cytoplasm+extension localization in the absence and presence of ILK.

Mutant

ILK

wt

+

Cytoplasm +
Extensions (%)
56 _+ 0.3
61 _+ 1.3 *

R169E

+

57 _+ 1.5
59 _+ 1.9

Δ7

+

54 _+ 1.5
57 _+ 0.9

186-418

+

46 _+ 2.2
46 _+ 5.0

1-350

+

25 _+ 1.5
28 _+ 3.6
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Table 3.5: Summary of ILK subcellular distribution in the absence and
presence of β-arrestin 1 mutants.

Mutant

Cytoplasm +
Extensions (%)

-

60 _+ 0.6

wt
R169E

61 _+ 1.3
59 _+ 1.9

Δ7

57 _+ 0.9

186-418
3A
1-365

46 _+ 5.0 *
63 _+ 3.3
58 _+ 3.3

1-350

37 _+ 1.5 *

1-173

55 _+ 2.7
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Figure 3.9. Subcellular localization of β-arrestin 1 R169E in the absence and
presence of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 R169E (A) or
with FLAG-tagged β-arrestin 1 R169E and V5-tagged mCherry-ILK (B) and processed
for immunofluorescence microscopy using antibodies against FLAG and V5 to visualize
-arrestin 1 R169E and ILK, respectively. Hoescht 33342 was used to visualize DNA.
One hundred cells were counted and the number of -arrestin 1 R169E -/+ ILK cells (C)
or ILK -/+ -arrestin 1 R169E cells (D) that exhibited localization throughout the
cytoplasm (termed cytoplasm only; C) or cytoplasmic localization with additional
localization along membrane extensions (termed cytoplasm+extensions; C+E) were
scored. Results are expressed as a mean +/- SEM (n=3). *p<0.05 (unpaired T-Test)
relative to single transfected cells. Bar, 16 m; Insets, highlight localization of indicated
proteins along membrane extensions.
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Figure 3.10. Subcellular localization of β-arrestin 1 Δ7 in the absence and presence
of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 Δ7 (A) or with
FLAG-tagged β-arrestin 1 Δ7 and V5-tagged mCherry-ILK (B) and processed for
immunofluorescence microscopy using antibodies against FLAG and V5 to visualize arrestin 1 Δ7 and ILK, respectively. Hoescht 33342 was used to visualize DNA. One
hundred cells were counted and the number of -arrestin 1 Δ7 -/+ ILK cells (C) or ILK
-/+ -arrestin 1 Δ7 cells (D) that exhibited localization throughout the cytoplasm (termed
cytoplasm only; C) or cytoplasmic localization with additional localization along
membrane extensions (termed cytoplasm+extensions; C+E) were scored. Results are
expressed as a mean +/- SEM (n=3). *p<0.05 (unpaired T-Test) relative to single
transfected cells. Bar, 16 m; Insets, highlight localization of indicated proteins along
membrane extensions.
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Figure 3.11. Subcellular localization of β-arrestin 1 3A in the absence and presence
of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 3A (A) or with
FLAG-tagged β-arrestin 1 3A and V5-tagged mCherry-ILK (B) and processed for
immunofluorescence microscopy using antibodies against FLAG and V5 to visualize arrestin 1 3A and ILK, respectively. Hoescht 33342 was used to visualize DNA. One
hundred cells were counted and the number of -arrestin 1 3A -/+ ILK cells (C) or ILK
-/+ -arrestin 1 3A cells (D) that exhibited localization throughout the cytoplasm (termed
cytoplasm only; C), cytoplasmic localization with additional localization along
membrane extensions (termed cytoplasm+extensions; C+E), or nuclear localization
(termed nucleus; N) were scored. Results are expressed as a mean +/- SEM (n=3).
*p<0.05 (unpaired T-Test) relative to single transfected cells. Bar, 16 m; Insets,
highlight localization of indicated proteins along membrane extensions.
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subcellular localization was unaffected by the presence of β-arrestin 1 3A (Figure 3.11BD; Tables 3.3 and 3.5; Appendix B). As was seen in the co-immunoprecipitation
experiments, the abundance of β-arrestin 1 3A in association with ILK was lower than
that of the wild-type protein (Section 3.6; Figure 3.7). Thus, the weaker interaction
between ILK and β-arrestin 1 3A observed in my biochemical analysis may be due, at
least in part, to the differences in subcellular distribution of these two proteins. My results
also suggest that Ile387, Val388 and Phe389 are important residues in determining the
subcellular localization of -arrestin 1 to the nucleus.
The -arrestin 1 mutants 186-418 and 1-350 were observed at membrane protrusions in
46% and 25% of cells, respectively (Figures 3.12A,C and 3.13A,C; Table 3.4; Appendix
B). These fractions were significantly lower than those observed in cells that expressed
the wild-type protein. -arrestin 1 1-350 localization along membrane protrusions was
also significantly lower than that of β-arrestin 1 186-418 (which contains the C-domain
only) (Figures 3.12A,C and 3.13A,C; Table 3.4; Appendix B). When ILK was coexpressed with -arrestin 1 186-418, a significant decrease in ILK localization to cell
protrusions was observed (45% of co-transfected cells) suggesting that this mutant can
interact with and possibly modify the ability of ILK to localize to these areas (Figure
3.12B,D; Tables 3.4 and 3.5; Appendix B). The β-arrestin 1 mutant 1-350 appeared to
have a similar inhibitory effect on ILK localization to cell extensions (Figure 3.13B,D;
Tables 3.4 and 3.5; Appendix B). In the presence of β-arrestin 1 1-350, ILK localized to
cell protrusions in only 37% of the co-transfected cells. In contrast, in the same
transfection samples, ILK was predominantly localized along the membrane in those cells
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Figure 3.12. Subcellular localization of β-arrestin 1 186-418 in the absence and
presence of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 186-418 (A) or
with FLAG-tagged β-arrestin 1 186-418 and V5-tagged mCherry-ILK (B) and processed
for immunofluorescence microscopy using antibodies against FLAG and V5 to visualize
-arrestin 1 186-418 and ILK, respectively. Hoescht 33342 was used to visualize DNA.
One hundred cells were counted and the number of -arrestin 1 186-418 -/+ ILK cells (C)
or ILK -/+ -arrestin 1 186-418 cells (D) that exhibited localization throughout the
cytoplasm (termed cytoplasm only; C) or cytoplasmic localization with additional
localization along membrane extensions (termed cytoplasm+extensions; C+E) were
scored. Results are expressed as a mean +/- SEM (n=3). *p<0.05 (unpaired T-Test)
relative to single transfected cells. Bar, 16 m; Insets, highlight localization of indicated
proteins along membrane extensions.
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Figure 3.13. Subcellular localization of β-arrestin 1 1-350 in the absence and
presence of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 1-350 (A) or with
FLAG-tagged β-arrestin 1 1-350 and V5-tagged mCherry-ILK (B) and processed for
immunofluorescence microscopy using antibodies against FLAG and V5 to visualize arrestin 1 1-350 and ILK, respectively. Hoescht 33342 was used to visualize DNA. One
hundred cells were counted and the number of -arrestin 1 1-350 -/+ ILK cells (C) or ILK
-/+ -arrestin 1 1-350 cells (D) that exhibited localization throughout the cytoplasm
(termed cytoplasm only; C) or cytoplasmic localization with additional localization along
membrane extensions (termed cytoplasm+extensions; C+E) were scored. Results are
expressed as a mean +/- SEM (n=3). *p<0.05 (unpaired T-Test) relative to single
transfected cells. Bar, 16 m; Insets, highlight localization of indicated proteins along
membrane extensions.

92

1-350

ILK

1-350
ILK
DNA

DNA

Cytoplasm only

Cytoplasm +
Extensions

A

Cytoplasm only

Cytoplasm +
Extensions

B

D
80

80

60

60

% Cells

% Cells

C

40
20

ILK

*

*

40
20

-

+
+
C
C+E
1-350 distribution

1-350

-

+
+
C
C+E
ILK distribution

93

that had not co-transfected with β-arrestin 1 1-350 (Figure 3.13B,D; Tables 3.4 and 3.5;
Appendix B).
-arrestin 1 1-365 was observed at membrane protrusions in only 4% of transfected cells
(Figures 3.14A,C; Table 3.3; Appendix B). Similar to β-arrestin 1 3A, which contains
point mutations within the C-domain, β-arrestin 1 1-365 was also observed in the nucleus
in 17% of cells (Figures 3.14A,C; Table 3.3; Appendix B). Finally, -arrestin 1 1-365
was found in perinuclear areas of the cell, with a unique pattern I refer to as “perinuclear”
in Figure 3.14 and Table 3.1, and which excluded ILK. Notably, the joint expression of
β-arrestin 1 1-365 and ILK significantly increased β-arrestin 1 1-365 localization to the
nucleus and to the perinuclear areas (Figure 3.14B,C and Table 3.3). These differences in
subcellular localization may help explain, at least in part, why a poor interaction between
ILK and β-arrestin 1 1-365 was observed by co-immunoprecipitation (Section 3.6; Figure
3.8).
-arrestin 1 1-173 (a mutant containing only the N-domain) was observed at membrane
protrusions in only 3% of transfected cells, significantly less than the wild-type and 186418 (Figures 3.15A,C; Table 3.3; Appendix B). Remarkably, -arrestin 1-173 was also
observed in the nucleus of 52% of cells (Figure 3.15A,C; Table 3.3; Appendix B), and
co-expression of ILK and -arrestin 1 1-173 did not alter the subcellular distribution of
these two proteins (Figure 3.15B-D; Tables 3.3 and 3.5; Appendix B). The differences in
subcellular localization between β-arrestin 1 1-173 and ILK may also contribute to the
poor association between these two proteins observed in co-immunoprecipitation assays
(Section 3.6; Figure 3.8).
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Figure 3.14. Subcellular localization of β-arrestin 1 1-365 in the absence and
presence of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 1-365 (A) or with
FLAG-tagged β-arrestin 1 1-365 and V5-tagged mCherry-ILK (B) and processed for
immunofluorescence microscopy using antibodies against FLAG and V5 to visualize arrestin 1 1-365 and ILK, respectively. Hoescht 33342 was used to visualize DNA. One
hundred cells were counted and the number of -arrestin 1 1-365 -/+ ILK cells (C) or ILK
-/+ -arrestin 1 1-365 cells (D) that exhibited localization throughout the cytoplasm
(termed cytoplasm only; C), cytoplasmic localization with additional localization along
membrane extensions (termed cytoplasm+extensions; C+E), nuclear localization (termed
nucleus; N), or perinuclear (termed other; P) were scored. Results are expressed as a
mean +/- SEM (n=3). *p<0.05 (unpaired T-Test) relative to single transfected cells. Bar,
16 m; Insets, highlight localization of indicated proteins along membrane extensions.
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Figure 3.15. Subcellular localization of β-arrestin 1 1-173 in the absence and
presence of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 1-73 (A) or with
FLAG-tagged β-arrestin 1 1-173 and V5-tagged mCherry-ILK (B) and processed for
immunofluorescence microscopy using antibodies against FLAG and V5 to visualize arrestin 1 1-173 and ILK, respectively. Hoescht 33342 was used to visualize DNA. One
hundred cells were counted and the number of -arrestin 1 1-173 -/+ ILK cells (C) or ILK
-/+ -arrestin 1 1-173 cells (D) that exhibited localization throughout the cytoplasm
(termed cytoplasm only; C), cytoplasmic localization with additional localization along
membrane extensions (termed cytoplasm+extensions; C+E), or nuclear localization
(termed nucleus; N) were scored. Results are expressed as a mean +/- SEM (n=3).
*p<0.05 (unpaired T-Test) relative to single transfected cells. Bar, 16 m; Insets,
highlight localization of indicated proteins along membrane extensions.
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The reduced membrane localization of -arrestin mutants containing either only the Ndomain (1-173) or only the C-domain (186-418) is consistent with the concept that both
domains are important contributors to the subcellular localization of β-arrestin 1. Given
that the N-domain-only mutant was observed along membrane protrusions significantly
less often than the C-domain-only mutant, it is possible that the C-domain in β-arrestin 1
is the major contributor to the ability of this protein to localize to membrane extensions
(Figure 3.16).
Among all mutants analyzed, those cells expressing -arrestin 1-173 exhibited the
greatest proportion of nuclear localization, indicating that the loss of the C-domain had
the greatest influence on nuclear import and/or retention (Figure 3.16). This observation,
coupled with the fact that wild-type -arrestin 1 and those mutants with an intact Cdomain did not exhibit nuclear localization, suggests that a possible nuclear export
domain exists within the C-domain of β-arrestin 1.

3.8

Optimization of keratinocyte chemotactic migration
assays

As ILK and β-arrestin 1 were found to colocalize along the membrane at areas of cell
extensions (Figure 3.5), and as lamellipodia formation is required for front-rear cell
polarity and directional migration, the next logical step in these studies was to investigate
whether ILK and β-arrestin 1 cooperate in promoting directional keratinocyte migration.
To this end, I first worked to establish experimental conditions to measure keratinocyte
migration responses to chemotactic signals from EGF gradients.
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3.16. Subcellular distribution of all β-arrestin 1 mutants.
Primary keratinocytes were transfected with the indicated FLAG-tagged -arrestin 1
mutants and processed for immunofluorescence microscopy as described in Figures 3.93.15. The percentage of cells with the indicated -arrestin 1 mutants localized along
membrane extensions (A) or in the nucleus (B) were quantified and graphed. Results are
expressed as a mean +/- SEM (n=3), ANOVA with post-hoc Tukey test was conducted.
*p<0.05 relative to β-arr 1. #p<0.05 relative to 186-418. ╪ p<0.05 relative to 1-173.
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I first seeded iKT cells onto Ibidi® chemotaxis µ-slides. Once the cells had adhered and
spread, they were exposed to an EGF gradient or vehicle, and images were acquired by
live-cell videomicroscopy for 8 hours.
In the presence of an EGF gradient, the cells migrated with an average speed of 0.64
µm/min, significantly greater than the 0.35 µm/min migration speed observed in cells
cultured in the absence of a chemoattractant gradient (Figure 3.17A). Further, in the
absence of EGF, 17%, 53% and 21% of cells examined exhibited mean velocities of 00.2 µm/min, 0.21-0.40 µm/min, and 0.41-0.60 µm/min, respectively, and only 9% of cells
showed mean velocities greater than 0.6 µm/min (Figure 3.17B). In the presence of an
EGF gradient, 36%, 29%, and 18% of the cells showed a speed of 0.41-0.6, 0.61-0.8 and
0.81-1 µm/min, respectively. Additionally, 5% of the cells migrated with a speed
between 1.01-1.20 µm/min (Figure 3.17B).
In agreement with the increased cell speed observed in EGF-containing cultures, these
cells showed a mean accumulated migration distance of 279 µm, almost 2-fold greater
than that observed in EGF-free cultures (154 µm, Figure 3.17C). In the absence of
chemoattractant, 26% and 50% of scored cells migrated 0-100 µm and 101-200 µm,
respectively (Figure 3.17D). Only 6% of cells migrated between distances of 301-400
µm. In contrast, only 1% of the cells cultured with EGF migrated between 0-100 µm, and
a majority of the cells migrated longer distances, with 42%, 21%, and 12% of cells
migrating 201-300 µm, 301-400, and 401-500 µm, respectively (Figure 3.17D).
Keratinocytes exposed to EGF exhibited a 2.5-fold greater Euclidean distance (distance
between the initial and final position) migrated (83.2 µm) relative to cells cultured
without EGF (33.9 µm, Figure 3.17E). Significantly, 78% of the cells in the absence of
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3.17. Exposure to EGF increases the speed, accumulated and Euclidean distances
migrated by keratinocytes.
Immortalized keratinocytes were seeded onto Ibidi® chemotaxis µ-slides and cultured for
18 hours, after which, they were exposed to an EGF gradient (50-0 ng/µl) or a control
condition without a chemoattractant, and imaged by live-cell videomicroscopy with one
image captured every 10 minutes for 8 hours. From the images obtained, 50-100 cells
were manually tracked, and the average speed (A), speed distribution (B), average
accumulated distance (C), accumulated distance distribution (D), average Euclidean
distance (E), and the Euclidean distance distribution (F), were calculated. Results are
expressed as a mean +/- SEM (n=3). For A, C, and E an unpaired student’s T-test was
conducted, with *p<0.05 relative to the control condition. For B, D, and F a one-way
ANOVA with post-hoc Tukey test was conducted, with *p<0.05 relative to the control
condition in the other intervals. #p<0.05 relative to the EGF condition in the other
intervals. Grey bars: control; Black bars: EGF.
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EGF showed a Euclidean migration distance of only 0-50 µm, whereas 35% and 19% of
cells exposed to EGF showed Euclidean migration distances of 51-100 and 101-150 µm,
respectively (Figure 3.17F).
The x-FMI of each individual cell is calculated by the ImageJ Chemotaxis & Migration
tool using the cell’s x,y coordinates at each time frame (with the cell’s initial position set
as 0,0), and provides a measure to describe the direction of cell migration in reference to
its starting position. Cells that migrated to the left of their starting position (towards the
EGF gradient) have a negative x-FMI score, whereas cells that migrated to the right of
their starting position (opposite direction of the EGF gradient) have a positive x-FMI
value. Trajectory plots of the migration path of each individual cell scored demonstrate
an overall movement towards the left in the EGF condition (Figure 3.18A,B).
Additionally, scatter plots of the x-FMI value of each individual cell scored showed that
the majority of cells cultured in the presence of EGF exhibited negative x-FMI values,
indicating migration towards the EGF gradient (Figure 3.18C,D). In contrast, those cells
cultured in the absence of EGF had a broader and more uniform distribution relative to
their start point, indicating a greater tendency for random, rather than directional, cell
migration (Figure 3.18).
With exposure to the EGF gradient, 46% of the cells had x-FMI values less than -0.02
and only 6% of cells had values greater than 0.02, demonstrating a high degree of
migration towards the EGF gradient (Figure 3.19A). Within the population of cells with
x-FMIs less than -0.2, a majority exhibited values between -0.21 and -0.6, however, few
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3.18. Migration patterns of each individual cell in the absence and presence of EGF.
Immortalized keratinocytes were seeded onto Ibidi® chemotaxis µ-slides and cultured for
18 hours, after which, they were exposed to an EGF gradient (50-0 ng/µl) or a control
condition without a chemoattractant, and imaged by live-cell videomicroscopy with one
image captured every 10 minutes for 8 hours. From the images obtained, 50-100 cells
were manually tracked. Representative trajectory plots of 25 tracked cells in the control
(A) and EGF (B) conditions. The x-axis forward migration index (x-FMI) of each
individual cell in the control (C) and EGF (D) conditions were calculated. Individual cells
are represented as grey circles. The black line indicates the point of origin. The cells
either migrated in the positive direction (to the right of their start position, in the EGF
condition this was away from the EGF gradient) or in the negative direction (to the left of
their start position, in the EGF condition this was towards the EGF gradient). The dashed
red line indicates the mean x-FMI.
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3.19. Keratinocytes exposed to EGF migrated in the direction of the EGF gradient.
Immortalized keratinocytes were seeded onto Ibidi® chemotaxis µ-slides and cultured for
18 hours, after which, they were exposed to an EGF gradient (50-0 ng/µl) or a control
condition without a chemoattractant, and imaged by live-cell videomicroscopy with one
image captured every 10 minutes for 8 hours. From the images obtained, 50-100 cells
were manually tracked, and the x-axis forward migration index (x-FMI) of each
individual cell was calculated. (A) The percent of cells that had values within the
indicated intervals were determined. The 0 interval represents the point of origin, cells in
this interval did not move along the x-axis. Negative intervals represent movement to the
left (or towards to the EGF gradient in the EGF condition) and positive intervals
represent movement to the right (or away from the EGF gradient in the EGF condition)
(B) The “less than -0.2” and “greater than 0.2” intervals were further divided into smaller
intervals to analyze the distribution pattern with greater precision. Results are expressed
as a mean +/- SEM (n=3). Grey bars: control; Black bars: EGF.
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cells had x-FMI values as far left as -0.8, showing a small degree of variability in the
responses to EGF, with some cells responding more strongly than others (Figure 3.19B).
Taken together, these results indicate that this assay is suitable for analyzing keratinocyte
chemotactic migration in response to EGF. Keratinocytes migrated faster and further than
those cultured without a chemoattractant, and their migration was directed towards the
EGF gradient. I next sought to investigate the role of β-arrestin 1 and ILK in chemotactic
migration. To this end, iKT cells were seeded onto the chemotaxis µ-slides and allowed
16-24 hours to adhere, at which point they were transfected with vectors encoding
mCherry and GFP, or mCherry-ILK and GFP-β-arrestin 1; however, no transfected cells
were observed. Therefore, iKT cells were transfected on 6-cm cell culture dishes, and 24
hours later they were trypsinized and re-seeded onto the chemotaxis µ-slides at a cell
density between 2x106-5x106 cells/ml. These cells did not adhere or spread, regardless of
passage number, cell density, or the addition of ECM substrates. By 24 hours after
plating, a majority of the cells had detached, indicating that this process resulted in loss
of cell viability. Due to these technical difficulties, I was unable to analyze the effect of
modulating ILK and β-arrestin 1 expression on EGF-induced chemotactic keratinocyte
migration. I encountered similar limitations with other assays developed to measure
directional migration.
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Chapter 4

4

Discussion

4.1

Summary

We have previously shown that ILK interacts with several proteins, such as ELMO2 and
RhoG, to modulate keratinocyte migration (Ho et al., 2009). β-arrestin 1 also interacts
with a wide-variety of proteins, including members of the MAPK family and cytoskeletal
proteins, such as cofilin and filamin A, to promote migration in a variety of cell types
(Scott et al., 2006; Zoudilova et al., 2007). Previous studies have also demonstrated a
selective cilium-restricted association between β-arrestin 2 and ILK in cerebellar granule
precursor cells (Barakat et al., 2013). My studies now demonstrate a previously
unidentified interaction between ILK and β-arrestin 1, which bind to each other in
primary mouse keratinocytes, as well as in immortalized human HaCaT keratinocytes.
This interaction requires the N-terminal 67 residues of ILK and multiple regions in βarrestin 1 (Figure 4.1). I have also determined that β-arrestin 1 localizes throughout the
cytoplasm of keratinocytes and, in addition, can localize to membrane protrusions.
Finally, ILK and β-arrestin 1 colocalize along membrane protrusions of keratinocytes,
suggesting a possible role for this complex in cell migration.

4.2

β-arrestin 1 interacts with the N-terminus of ILK

The interaction between ILK and β-arrestin 1 involves direct binding of these two
proteins to each other and does not require post-translational modifications (Figure 4.1).
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Figure 4.1. Proposed model for β-arrestin 1 and ILK interaction. ILK and β-arrestin
1 directly bind to each other. This interaction requires the N-terminal 67 residues of ILK
and multiple regions of β-arrestin 1, with specific contribution from amino acid residues
Ile387, Val388, and Phe389 of the C-domain. Abbreviations: A1-5, Ankyrin repeats 1-5; PH,
Pleckstrin homology-like domain; KLD, Kinase-like domain; IDH, Inter-domain hinge.
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β-arrestin 1 associates with ILK E359K, an ILK mutant form with impaired scaffold
properties and unable to localize to focal adhesions (Nikolopoulos and Turner, 2002).
This interaction suggests that the presence of either ILK or β-arrestin 1 at focal adhesions
is likely not required for their interaction to take place and that the ILK-β-arrestin 1
interaction may occur independent of focal adhesions. To confirm this, experiments
investigating colocalization of this complex with other bona fide focal adhesion proteins,
such as paxillin or vinculin, would need to be conducted.
ILK 1-192, an ILK truncation mutant missing the pseudokinase domain, also interacts
with β-arrestin 1, suggesting that the pseudokinase domain is not necessary for the
formation of ILK-β-arrestin 1 complexes. This association is unlike the interaction
between ILK and other proteins, such as paxillin and parvins, for which the pseudokinase
domain is indispensable (Wu and Dedhar, 2001; Nikolopoulos and Turner, 2001).
ILK also binds to various other proteins, such as PINCH, through its ankyrin repeats
(Chiswell et al., 2008). ILK 67-452 is missing the first two N-terminal ankyrin repeats,
rendering it unable to interact with PINCH (Tu et al., 1999). I have shown that these first
67 residues of ILK are also important for binding to β-arrestin 1, although my
experiments do not elucidate if this interaction requires the ankyrin repeats specifically,
since there are linker regions between each repeat. To determine the importance of the
putative ankyrin repeats on the ILK-β-arrestin 1 interaction, ILK proteins in which the
tetrapeptide “TPLH” motifs are mutated, abrogating the helix-turn-helix structure, would
need to be assessed for their ability to bind β-arrestin 1.
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4.3

The conformational arrangement of β-arrestin 1 does
not affect its interaction with ILK

β-arrestin 1 can exist in a “closed” or an “open” conformation. In the basal state, βarrestin 1 is maintained in the “closed” conformation mainly by two intramolecular
interactions. An interaction between hydrophobic residues from the N- and C-domains,
referred to as the three-element region, and an interaction between oppositely charged
residues from both domains, referred to as the polar core region (Figure 1.3;
Vishnivetskiy et al., 1999; Kovoor et al., 1999; Vishnivetskiy et al., 2000; Han et al.,
2001; Nobles et al., 2007). Disruption of either of these intramolecular interactions yields
a more dynamic and open conformation (Kovoor et al., 1999; Vishnivetskiy et al., 2000;
Kim et al., 2015).
I have shown that ILK interacts efficiently with β-arrestin 1 mutants that exist in either
the “open” or “closed” form. Similar findings have been reported with other β-arrestin 1binding proteins, such as the MAPK proteins ERK1/2 and MEK1. Specifically, ERK1/2
and MEK1 can associate with β-arrestin 1 3A (a β-arrestin 1 mutant form that has an
“open” conformation), as well as β-arrestin 1 Δ7 (a mutant form that maintains β-arrestin
1 in a “closed” conformation) (Coffa et al., 2011). The binding of ERK1/2 to β-arrestin 1
modulates ERK1/2 activity. Binding to the “open” form of β-arrestin 1 facilitates ERK1/2
activation, whereas binding to the “closed” form maintains ERK1/2 in an inactive state
(Hanson et al., 2007; Coffa et al., 2011). Binding of ILK to these different β-arrestin 1
forms may have different functional outcomes. Future experiments would need to
investigate this possibility. This type of investigation could be accomplished by using βarrestin 1-deficient keratinocytes, introducing the various mutant forms of β-arrestin 1 as
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well as ILK proteins that do or do not interact with β-arrestin 1, and assessing changes in
cellular functions, such as migration.
The apparent ability of ILK to interact with β-arrestin 1 in either the “open” or the
“closed” conformations contrasts with some other β-arrestin 1-binding proteins. For
example, GPCRs, clathrin and AP-2 can only bind the “open” form of β-arrestin 1 (Kim
and Benovic, 2002). Conversely, microtubules and calmodulin preferentially bind βarrestin 1 when it is in the “closed” conformation (Wu et al., 2006; Hanson et al., 2007).

4.4

ILK

and

β-arrestin

1

colocalize

at

membrane

protrusions
In this present study, I have shown that ILK and β-arrestin 1 can colocalize at cell
extensions. β-arrestin 1 contains membrane-binding regions in both the N- and the Cdomain. It has been suggested that the amphipathic α-helix of β-arrestin 1, composed of
residues 98-108 of the N-domain, serves as a reversible membrane anchor (Han et al.
2001; Hoeppner et al. 2012). Additionally, residues Lys232-Lys326 of the C-domain
participate in binding to phosphoinositides, at the plasma membrane (Gaidarov et al.,
1999; Milano et al., 2002). It is possible that these regions are also involved in the
localization or maintenance of the ILK-β-arrestin 1 complex at the membrane.
Expression of a C-domain-only β-arrestin 1 mutant, which lacks the amphipathic α-helix,
resulted in a decrease in membrane localization of ILK, similar to the β-arrestin 1 mutant
1-350, which lacks the phosphoinositide binding sites. Further, the β-arrestin 1 mutant 1350 was observed at membrane extensions less often compared to the C-domain-only
mutant. This observation suggests that while both the N- and C-domain of β-arrestin 1
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may be required for either localizing to or stabilizing the ILK-β-arrestin 1 complexes at
the membrane, it appears that the C-domain may be the major contributor. Further
investigation is required to elucidate whether this complex forms and is subsequently
recruited to the membrane, or if it is formed at the membrane.

4.5

Possible role of the β-arrestin 1 C-domain in regulating
nuclear export and import of β-arrestin 1

Proteins smaller than approximately 50 kDa can passively diffuse between the nucleus
and cytoplasm through nuclear pores (Samudram et al., 2016). The N- and C-domainonly β-arrestin 1 mutants used in this present study are approximately 21 and 27 kDa,
respectively. As such, it seems possible that these proteins could passively diffuse
between the nucleus and cytoplasm, and be found relatively evenly distributed between
these two subcellular compartments. However, the C-domain-only β-arrestin 1 mutant
was found primarily in the cytoplasm and seemed to be excluded from the nucleus,
suggesting the possible presence of an export signal in the C-domain of β-arrestin 1.
CRM1-mediated export is a well-characterized nuclear export pathway. CRM1, a
member of the karyopherin-β family of importins and exportins, is located in the nucleus,
where it recognizes and binds to proteins containing a leucine-rich NES. Through
interactions with the GTPase, Ran-GTP, the NES-CRM1-Ran-GTP complex exits the
nucleus through the nuclear pore complex (Fornerod et al., 1997). In the cytoplasm, the
hydrolysis of Ran-GTP to Ran-GDP induces the dissociation of the NES-protein from
CRM1. Leptomycin B (LMB) is a compound that prevents CRM1-NES binding,
irreversibly inhibiting CRM1-mediated protein export (Kudo et al., 1999).
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Of the four mammalian arrestin family members, only β-arrestin 2 contains a canonical
NES, which includes amino acid residues Leu395/Leu397, and shuttles between the
cytoplasm and the nucleus in a CRM1-dependent manner (Scott et al., 2002). The
corresponding sequence in β-arrestin 1 differs by a single amino acid, a glutamine at
position 395 in place of the leucine. β-arrestin 2 mutants containing a L395Q mutation
are insensitive to LMB, suggesting that this amino acid difference between β-arrestin 1
and 2 prevents CRM1-mediated export of β-arrestin 1.
A possible explanation for the effect of the C-domain on nuclear exclusion is that the Cdomain participates in CRM1-independent nuclear export. Exportin 6 is another member
of the karyopherin-β family, and it mediates the nuclear export of profilin-actin
complexes (Stüven et al., 2003). In this role, exportin 6 regulates the balance between
nuclear and cytoplasmic actin pools. Smad3 is also exported through a LMB-insensitive
pathway, and is instead exported through exportin 4 (Kurisaki et al., 2006). Other
possible mechanisms of nuclear export include importin 13, which was initially thought
to be involved strictly in protein import, but was also shown to mediate Ran-GTP
independent export of various proteins (Mingot et al., 2001). Some proteins, such as
Smad2, exhibit intrinsic nuclear export activity. Smad2 can directly bind to nucleoporins
in the nuclear pore complex, and regulate its own nuclear export (Xu et al., 2002). It may
be possible that the C-domain of β-arrestin 1 regulates β-arrestin 1 export through any
one of these mechanisms, or through an undiscovered CRM1-independent pathway.
The subcellular localization of the N-domain-only β-arrestin 1 protein also appears to be
uncharacteristic of proteins that passively diffuse in and out of the cytoplasm. Instead,
when the N-domain-only β-arrestin 1 mutant is localized to the nucleus, it appears to be
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absent from the cytoplasm. This is consistent with the presence of a nuclear localization
sequence (NLS) within the N-domain of β-arrestin 1. Proteins containing a NLS bind to
importin receptors in the cytoplasm (Christie et al., 2016). The NLS-importin complexes
enter the nucleus through the nuclear pore complex, where the NLS protein is released
upon RanGTP binding to the importin. Previous studies have shown that the N-domain of
β-arrestin 1 contains a 7-amino acid NLS, encompassing residues Lys157-Arg161/Arg169Lys170, allowing for nuclear import (Hoeppner et al., 2012). Deletion of the C-domain
may remove the nuclear export sequences in β-arrestin 1, explaining the significant
increase in nuclear localization of the N-domain-only β-arrestin 1 protein.

4.6

Other potential roles of the β-arrestin 1 C-domain

The observed lower protein levels of the C-domain-lacking β-arrestin 1 mutants 1-173, 1350 and 1-365 relative to the other mutants and wildtype β-arrestin 1, suggests a possible
role for the C-domain in protein stability. One possibility is that it provides a means for
correct protein folding. Two major contributing factors to protein stability include
hydrogen bonding and hydrophobic interactions (Pace et al., 2004). The C-domain
contains most of the polar core residues, which form hydrogen bonds and maintain βarrestin 1 in the basal conformation (Vishnivetskiy et al., 1999). Without these
interactions, the C-domain-lacking mutants 1-173, 1-350 and 1-365 may have a tendency
to misfold when translated. Once misfolded, proteins are targeted to the proteasome for
degradation (Bukau et al., 2006). To determine whether these proteins are being targeted
for proteasomal degradation, the effect of proteasomal inhibitors, such as MG132, on βarrestin 1 1-173, 1-350 and 1-365 abundance would need to be assessed.
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Other factors that contribute to protein stability include protein-protein interactions and
post-translational modifications. As a scaffold protein, β-arrestin 1 binds numerous
proteins through its C-domain; as such, it is possible that these interactions aid in
stabilizing β-arrestin 1. Additionally, post-translational modifications, such as
phosphorylation, to the β-arrestin 1 C-domain may prevent proteasomal targeting (Lin et
al., 1999).

4.7

β-arrestin
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A naturally occurring, constitutively active splice variant of visual arrestin (arrestin-1),
termed P44, shares 75% homology with the β-arrestin 1 mutant 1-365 (Smith et al.,
1994). P44 demonstrates higher affinity for microtubules than the full-length arrestin-1
(Nair et al., 2004). In my studies, β-arrestin 1 1-365 was not detected at the membrane,
possibly due to the loss of the phosphoinositide binding sites within the C-domain. It also
localized to the nucleus, likely due to the NLS located in the N-domain. However, the
localization of β-arrestin 1 1-365 to the perinuclear region was unusual and unique, as
such I first investigated whether β-arrestin 1 1-365 colocalized with microtubules. There
appeared to be partial colocalization around the nucleus, however further colocalization
assays are required to confirm these findings (Appendix C). Additionally, the effect of
reagents that disrupt microtubule dynamics, such as colchicine, on β-arrestin 1 1-365
localization would need to be assessed.
.
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4.8

Preliminary studies to assess chemotactic keratinocyte
migration

EGFR signaling plays an important role in keratinocyte migration. Common methods to
investigate the effect of EGF on keratinocyte migration include Boyden Chamber or
scratch-wound assays. These assays provide an initial and final position of the
keratinocytes, from which the distance migrated, can be determined. The chemotactic
assay used in this study provides a stable, linear gradient of EGF for directional
movement of keratinocytes, and allows for visualization of the cells throughout the
experiment (Eiseler et al., 2009). This assay also allows the quantification of cell speed,
accumulated distance and Euclidean distance travelled, and an absolute value for the
overall direction of cell migration. This allows for confirmation that the migration is
chemotactic (directional), rather than chemokinetic (random).
The significant increase observed in the average Euclidean distance (distance from start
to finish) migrated by the cells in the presence of EGF is consistent with previous reports
(Koivisto et al., 2003; Ho et al., 2009; Watson et al., 2009). However, the present study
further demonstrates, in greater detail, the effects of EGF on keratinocyte migration. EGF
stimulation resulted in increased accumulated distance migrated, as well as speed at
which the cells travelled. Furthermore, the EGF gradient promoted directional movement
of the cells towards the EGF gradient, which was otherwise random in the absence of
EGF.
There were a few factors of this assay, such as the small surface area and volume of the
chamber affecting the amount of growth medium added, and delayed cell spreading, that
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may have contributed to my inability to perform this assay with transfected cells. The
defective cell attachment and spreading on the chemotaxis chambers was observed in all
cells from the transfected keratinocyte samples. This abnormal cell attachment and
spreading may be due, although not exclusively, to the transfection procedure.
Additionally, it may be possible that these phenotypes can also be attributed to
environment of the chemotaxis chambers, such as the small volume and surface area, or
the treatment process of the plastic, as a portion of these transfected cells were also reseeded onto 24-well plates where they adhered and spread normally. A key next step for
future experiments will be to develop conditions in which the overexpression or silencing
of β-arrestin 1 and/or ILK does not compromise cell viability during assays that measure
cell motility.
If the transfected keratinocytes had adhered, the chemotaxis experiment with these cells
could have had several potential outcomes. For example, the localization of β-arrestin 1
and ILK observed at cell extensions could have contributed to the production of a stable
leading edge, promoting directional migration. In this case, an increase in EGF-induced
migration would have been observed. Alternatively, overexpression of these two proteins
and their localization at cell edges could have contributed to the production of multiple
cell protrusions around the cell, rather than in a polarized fashion, which would actually
impede migration. In this scenario, a decrease in keratinocyte migration would have been
observed. Additionally, the overexpression of these two proteins could have resulted in
no change in migration. This would have suggested that either they do not regulate EGFinduced migration, or the endogenous levels were already saturating the response, and
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their overexpression would not have had any additional effects. Future experiments will
need to address the involvement of this complex in modulating keratinocyte migration.

4.9

Future directions

I have identified a mutant form of ILK that has severely impaired interactions with βarrestin 1. By introducing this mutant in ILK-deficient keratinocytes, it can be determined
whether the ILK-β-arrestin 1 interaction is crucial in promoting keratinocyte migration,
as well as determining if there are other cellular processes this complex may modulate.
Additionally, although an intact ILK pseudokinase domain is not required for the
interaction with β-arrestin 1, the possibility that it may be necessary to facilitate
interactions with other, unidentified downstream effectors of this complex remains to be
tested.
β-arrestin 1 and ILK, separately, function in the remodeling of the actin cytoskeleton.
ILK promotes Rac1 activation, which in turn leads to F-actin reorganization and
directional migration (Ho and Dagnino, 2012). β-arrestin 1 scaffolds multiple F-actin
regulatory proteins at membrane protrusions, leading to F-actin polymerization and also
directional migration (Scott et al., 2006; Zoudilova et al., 2007). These two proteins may
cooperate in modulating actin cytoskeletal dynamics. Investigating the changes in F-actin
reorganization in response to overexpression of ILK-β-arrestin 1 complexes, or β-arrestin
1 and ILK forms that do not interact, as well as identification of F-actin regulatory
proteins that may form ternary complexes with β-arrestin 1 and ILK, would provide
additional insight into the role of this ILK-β-arrestin 1 complex in regulation of
cytoskeletal dynamics.
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ILK is involved in growth factor receptor signaling. For example, ILK participates in
EGF-induced migration of keratinocytes (Ho and Dagnino, 2012). Similarly, a few
studies have demonstrated β-arrestin 1-dependent migration in response to growth
factors, such as IGF-1 (Girnita et al., 2012). As such, it would be interesting to
investigate the requirement of ILK-β-arrestin 1 complexes in growth factor signaling.
Furthermore, ILK has been reported to associate with β-arrestin 2 and modulate signaling
of the GPCR, Smoothened. It may be of interest to examine if ILK-β-arrestin 1
complexes also play a role in GPCR signaling. Of particular interest, it has recently been
reported that the activation of the angiotensin-II receptor type 1 (AT1R) induces βarrestin 2-dependent keratinocyte migration. It would be interesting to investigate the
possibility of ILK involvement in this process. In addition, given that both β-arrestin 1
and ILK have been shown to be involved in receptor cross-talk, it seems possible that
these two proteins may collaborate in bridging GPCRs and receptor tyrosine kinases.

4.10 Concluding remarks
Here, I have presented evidence for a novel interaction between ILK and β-arrestin 1,
which requires the N-terminal 67 residues of ILK for optimal binding of these two
proteins. The colocalization of these proteins at cell protrusions requires the presence of
both the N- and C- domains of β-arrestin 1, and suggests a possible role for this complex
in keratinocyte migration. Future work is necessary to provide functional evidence for the
role of this complex in this process.
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Appendices
Appendix A: Additional representative fluorescence micrographs depicting βarrestin 1 and/or ILK.
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Figure A1. Subcellular localization of β-arrestin 1.
Primary keratinocytes were transfected with Flag-tagged β-arrestin 1 and processed for
immunofluorescence microscopy using antibodies against FLAG. Hoescht 33342 was
used to visualize DNA. Bar, 16 μm.
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Figure A2. Subcellular localization of ILK.
Primary keratinocytes were transfected with V5-tagged ILK and processed for immunofluorescence microscopy using antibodies against V5. Hoescht 33342 was used to visualize DNA. Bar, 16 μm.
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Figure A3. Subcellular localization of β-arrestin 1 and ILK.
Primary keratinocytes were transfected with Flag-tagged β-arrestin 1 and V5-tagged ILK
and processed for immunofluorescence microscopy using antibodies against FLAG and
V5. Hoescht 33342 was used to visualize DNA. Bar, 16 μm.
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Appendix B: Additional representative fluorescence micrographs depicting βarrestin 1 mutants in the absence or presence of ILK.
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Figure B1. Subcellular localization of β-arrestin 1 R169E in the absence and
presence of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 R169E with or
without V5-tagged ILK and processed for immunofluorescence microscopy using
antibodies against FLAG and V5 to visualize -arrestin 1 R169E and ILK, respectively.
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Figure B2. Subcellular localization of β-arrestin 1 Δ7 in the absence and presence of
ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 Δ7 with or
without V5-tagged ILK and processed for immunofluorescence microscopy using
antibodies against FLAG and V5 to visualize -arrestin 1 Δ7 and ILK, respectively.
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Figure B3. Subcellular localization of β-arrestin 1 3A in the absence and presence of
ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 3A with or
without V5-tagged ILK and processed for immunofluorescence microscopy using
antibodies against FLAG and V5 to visualize -arrestin 1 R169E and ILK, respectively.
Hoescht
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was

used

to

visualize

DNA.

Cells

were

categorized

as

cytoplasm+extensions (cytoplasmic localization with additional localization along
membrane extensions), cytoplasm only (localization throughout the cytoplasm), or
nucleus (nuclear localization). Bar, 16 µm.
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Figure B4. Subcellular localization of β-arrestin 1 186-418 in the absence and
presence of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 186-418 with or
without V5-tagged ILK and processed for immunofluorescence microscopy using
antibodies against FLAG and V5 to visualize -arrestin 1 186-418 and ILK, respectively.
Hoescht
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to

visualize
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Cells
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as

cytoplasm+extensions (cytoplasmic localization with additional localization along
membrane extensions), or cytoplasm only (localization throughout the cytoplasm). Bar,
16 µm.
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Figure B5. Subcellular localization of β-arrestin 1 1-350 in the absence and presence
of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 1-350 with or
without V5-tagged ILK and processed for immunofluorescence microscopy using
antibodies against FLAG and V5 to visualize -arrestin 1 1-350 and ILK, respectively.
Hoescht

33342

was

used

to

visualize

DNA.

Cells

were

categorized

as

cytoplasm+extensions (cytoplasmic localization with additional localization along
membrane extensions), or cytoplasm only (localization throughout the cytoplasm). Bar,
16 µm.
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Figure B6. Subcellular localization of β-arrestin 1 1-365 in the absence and presence
of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 1-365 with or
without V5-tagged ILK and processed for immunofluorescence microscopy using
antibodies against FLAG and V5 to visualize -arrestin 1 1-365 and ILK, respectively.
Hoescht 33342 was used to visualize DNA. Cells were categorized as cytoplasm only
(localization throughout the cytoplasm), nucleus (nuclear localization), or other. Bar, 16
µm.
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Figure B7. Subcellular localization of β-arrestin 1 1-173 in the absence and presence
of ILK.
Primary keratinocytes were transfected with FLAG-tagged -arrestin 1 1-173 with or
without V5-tagged ILK and processed for immunofluorescence microscopy using
antibodies against FLAG and V5 to visualize -arrestin 1 1-173 and ILK, respectively.
Hoescht 33342 was used to visualize DNA. Cells were categorized as cytoplasm only
(localization throughout the cytoplasm), or nucleus (nuclear localization). Bar, 16 µm.
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Appendix C: β-arrestin 1 partially colocalizes with β-tubulin.
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Figure C1. β-arrestin 1 1-365 may co-localize with β-tubulin.
Primary keratinocytes were transfected with FLAG-tagged β-arrestin 1 1-365, and
processed for immunofluorescence microscopy using antibodies against FLAG and
β-tubulin. Hoescht 33342 was used to visualize DNA
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